Unity Bancorp (UNTY) 10-Q 5 May 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Apr. 30, 2020
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity Registrant Name	UNITY BANCORP INC /NJ/
Entity Central Index Key	0000920427
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		10,883,281

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
ASSETS
Cash and due from banks	$ 20,377	$ 21,106
Federal funds sold and interest-bearing deposits	158,618	136,910
Cash and cash equivalents	178,995	158,016
Securities:
Debt securities available for sale (amortized cost of $55,894 in 2020 and $63,883 in 2019)	56,290	64,275
Equity securities with readily determinable fair values (amortized cost of $2,112 in 2020 and $2,218 in 2019)	1,712	2,289
Total securities	58,002	66,564
Loans:
SBA loans held for sale	10,726	13,529
Loans	1,428,919	1,412,029
Total loans	1,439,645	1,425,558
Allowance for loan losses	(17,376)	(16,395)
Net loans	1,422,269	1,409,163
Premises and equipment, net	21,046	21,315
Bank owned life insurance (BOLI)	26,379	26,323
Deferred tax assets	6,305	5,559
Federal Home Loan Bank (FHLB) stock	9,054	14,184
Accrued interest receivable	7,396	6,984
Other real estate owned (OREO)	1,523	1,723
Goodwill	1,516	1,516
Prepaid expenses and other assets	7,591	7,595
Total assets	1,740,076	1,718,942
Deposits:
Noninterest-bearing demand	334,731	279,793
Interest-bearing demand	166,990	176,335
Savings	388,213	389,795
Time, under $100,000	278,776	195,446
Time, $100,000 to $250,000	121,656	126,192
Time, $250,000 and over	88,252	82,553
Total deposits	1,378,618	1,250,114
Borrowed funds	169,000	283,000
Subordinated debentures	10,310	10,310
Accrued interest payable	237	455
Accrued expenses and other liabilities	17,606	14,354
Total liabilities	1,575,771	1,558,233
Shareholders' equity:
Common stock	90,370	90,113
Retained earnings	74,939	70,442
Treasury stock	(172)	0
Accumulated other comprehensive (loss) income	(832)	154
Total shareholders' equity	164,305	160,709
Total liabilities and shareholders' equity	$ 1,740,076	$ 1,718,942
Issued common shares (in shares)	10,894	10,881
Outstanding common shares (in shares)	10,883	10,881
Treasury shares (in shares)	11	0
SBA loans
Loans:
Loans	$ 37,074	$ 35,767
Commercial loans
Loans:
Loans	786,078	765,032
Residential mortgage loans
Loans:
Loans	456,072	467,706
Consumer loans
Loans:
Loans	$ 149,695	$ 143,524

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Securities available for sale, amortized cost basis	$ 55,894	$ 63,883
Equity securities, amortized cost basis	$ 2,112	$ 2,218

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
INTEREST INCOME
Federal funds sold and interest-bearing deposits	$ 188	$ 221
FHLB stock	109	116
Securities:
Taxable	511	475
Tax-exempt	22	29
Total securities	533	504
Loans:
SBA loans	985	995
Commercial loans	9,933	9,069
Residential mortgage loans	5,770	5,560
Consumer loans	2,067	2,035
Total loans	18,755	17,659
Total interest income	19,585	18,500
INTEREST EXPENSE
Interest-bearing demand deposits	478	409
Savings deposits	851	1,119
Time deposits	2,447	2,007
Borrowed funds and subordinated debentures	565	749
Total interest expense	4,341	4,284
Net interest income	15,244	14,216
Provision for loan losses	1,500	500
Net interest income after provision for loan losses	13,744	13,716
NONINTEREST INCOME
Branch fee income	317	368
Service and loan fee income	376	442
Gain on sale of SBA loans held for sale, net	473	316
Gain on sale of mortgage loans, net	1,051	350
BOLI income	173	151
Net security (losses) gains	(170)	100
Other income	325	295
Total noninterest income	2,545	2,022
NONINTEREST EXPENSE
Compensation and benefits	5,439	4,845
Occupancy	624	694
Processing and communications	708	716
Furniture and equipment	655	659
Professional services	332	288
Loan collection and OREO expenses	186	66
Other loan expenses	89	46
Deposit insurance	88	167
Advertising	290	348
Director fees	200	163
Other expenses	712	486
Total noninterest expense	9,323	8,478
Income before provision for income taxes	6,966	7,260
Provision for income taxes	1,598	1,520
Net income	$ 5,368	$ 5,740
Net income per common share - Basic (in dollars per share)	$ 0.49	$ 0.53
Net income per common share - Diluted (in dollars per share)	$ 0.49	$ 0.52
Weighted average common shares outstanding - Basic (in shares)	10,883	10,801
Weighted average common shares outstanding - Diluted (in shares)	11,037	10,955

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Net income, before tax amount	$ 6,966	$ 7,260
Income tax expense	1,598	1,520
Net income	5,368	5,740
Debt securities available for sale:
Unrealized holding gains on securities arising during the period, before tax	(166)	313
Unrealized holding gains on securities arising during the period, tax	(35)	73
Unrealized holding gains on securities arising during the period, net	(131)	240
Less: reclassification adjustment for gains on securities included in net income, before tax	(170)	100
Less: reclassification adjustment for gains on securities included in net income, tax	(36)	21
Total reclassification adjustment for gains on securities included in net income	(134)	79
Total unrealized gains on securities available for sale, before tax	4	213
Total unrealized gains on securities available for sale, tax	1	52
Total unrealized gains on securities available for sale, net of tax	3	161
Adjustments related to defined benefit plan:
Amortization of prior service cost, before tax	21	21
Amortization of prior service cost, tax	6	(70)
Amortization of prior service cost, net of tax	15	91
Total adjustments related to defined benefit plan, before tax	21	21
Total adjustments related to defined benefit plan, tax	6	(70)
Total adjustments related to defined benefit plan	15	91
Net unrealized losses from cash flow hedges:
Unrealized holding loss on cash flow hedges arising during the period, before tax	(1,410)	(408)
Unrealized holding loss on cash flow hedges arising during the period, tax	(406)	(106)
Unrealized holding loss on cash flow hedges arising during the period, net of tax	(1,004)	(302)
Total unrealized loss on cash flow hedges, before tax	(1,410)	(408)
Total unrealized loss on cash flow hedges, tax	(406)	(106)
Total unrealized loss on cash flow hedges, net of tax	(1,004)	(302)
Total other comprehensive income, before tax	(1,385)	(174)
Total other comprehensive income, tax	(399)	(124)
Total other comprehensive income, net	(986)	(50)
Total comprehensive income, before tax	5,581	7,086
Total comprehensive income, tax	1,199	1,396
Total comprehensive income	$ 4,382	$ 5,690

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands		Total	Stock	Retained earnings	Accumulated other comprehensive income (loss)	Treasury stock
Beginning Balance at Dec. 31, 2018		$ 138,488	$ 88,484	$ 50,161	$ (157)
Beginning Balance (in shares) at Dec. 31, 2018			10,780
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		5,740		5,740
Other comprehensive loss, net of tax		(50)			(50)
Dividends on common stock		(730)	$ 26	(756)
Common stock issued and related tax effects	[1]	269	$ 269
Common stock issued and related tax effects (in shares)	[1]		42
Ending Balance at Mar. 31, 2019		143,717	$ 88,779	55,145	(207)
Ending Balance (in shares) at Mar. 31, 2019			10,822
Beginning Balance at Dec. 31, 2019		$ 160,709	$ 90,113	70,442	154	$ 0
Beginning Balance (in shares) at Dec. 31, 2019		10,881	10,881
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		$ 5,368		5,368
Other comprehensive loss, net of tax		(986)			(986)
Dividends on common stock		(841)	$ 30	(871)
Common stock issued and related tax effects	[1]	227	$ 227
Common stock issued and related tax effects (in shares)	[1]		13
Acquisition of treasury stock, at cost (in shares)			(11)
Acquisition of treasury stock, at cost		(172)				(172)
Ending Balance at Mar. 31, 2020		$ 164,305	$ 90,198	$ 74,939	$ (832)	$ (172)
Ending Balance (in shares) at Mar. 31, 2020		10,883	10,883
[1]	Includes the issuance of common stock under employee benefit plans, which includes nonqualified stock options and restricted stock expense related entries, employee option exercises and the tax benefit of options exercised.

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Shareholders' Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Stockholders' Equity [Abstract]
Dividends per share, cash paid (in dollars per share)	$ 0.08	$ 0.07

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
OPERATING ACTIVITIES:
Net income	$ 5,368,000	$ 5,740,000
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses	1,500,000	500,000
Net amortization of purchase premiums and discounts on securities	59,000	37,000
Depreciation and amortization	317,000	121,000
Deferred income tax (benefit) expense	(347,000)	82,000
Net security gains	(301,000)	0
Stock compensation expense	365,000	283,000
Valuation writedowns on OREO	200,000	0
Gain on sale of mortgage loans held for sale, net	(622,000)	(258,000)
Gain on sale of SBA loans held for sale, net	(473,000)	(316,000)
Origination of mortgage loans held for sale	(38,562,000)	(19,431,000)
Origination of SBA loans held for sale	(2,595,000)	(2,412,000)
Proceeds from sale of mortgage loans held for sale, net	39,184,000	19,689,000
Proceeds from sale of SBA loans held for sale, net	5,850,000	6,511,000
BOLI income	(173,000)	(151,000)
Net change in other assets and liabilities	1,714,000	819,000
Net cash provided by operating activities	11,484,000	11,214,000
INVESTING ACTIVITIES
Purchases of FHLB stock, at cost	(22,275,000)	(20,295,000)
Maturities and principal payments on securities held to maturity	0	89,000
Maturities and principal payments on debt securities available for sale	2,198,000	959,000
Proceeds from sales of securities available for sale	6,029,000	0
Proceeds from sales of equity securities	111,000	0
Proceeds from redemption of FHLB stock	27,405,000	20,970,000
Net increase in loans	(17,277,000)	(12,541,000)
Proceeds from BOLI	117,000	0
Purchases of premises and equipment	(166,000)	(109,000)
Net cash used in investing activities	(3,858,000)	(10,927,000)
FINANCING ACTIVITIES
Net increase in deposits	128,504,000	18,899,000
Proceeds from new borrowings	109,000,000	175,000,000
Repayments of borrowings	(223,000,000)	(190,000,000)
Proceeds from exercise of stock options	34,265	165,943
Fair market value of shares withheld to cover employee tax liability	(172,000)	0
Dividends on common stock	(841,000)	(730,000)
Purchase of treasury stock	(172,000)	0
Net cash provided by financing activities	13,353,000	3,335,000
Increase in cash and cash equivalents	20,979,000	3,622,000
Cash and cash equivalents, beginning of period	158,016,000	145,515,000
Cash and cash equivalents, end of period	178,995,000	149,137,000
SUPPLEMENTAL DISCLOSURES
Interest paid	4,559,000	4,271,000
Income taxes paid	1,782,000	52,000
Noncash investing activities:
Establishment of lease liability and right-of-use asset	0	2,765,000
Transfer of SBA loans held for sale to held to maturity	1,024,000	0
Capitalization of servicing rights	486,000	211,000
Transfer of loans to OREO	$ 0	$ 328,000

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies The accompanying Consolidated Financial Statements include the accounts of Unity Bancorp, Inc. (the "Parent Company") and its wholly-owned subsidiary, Unity Bank (the "Bank" or when consolidated with the Parent Company, the "Company"), and reflect all adjustments and disclosures which are generally routine and recurring in nature, and in the opinion of management, necessary for a fair presentation of interim results. The Bank has multiple subsidiaries used to hold part of its investment and loan portfolios and OREO properties. All significant intercompany balances and transactions have been eliminated in consolidation. Certain reclassifications have been made to prior period amounts to conform to the current year presentation, with no impact on current earnings or shareholders’ equity. The financial information has been prepared in accordance with U.S. generally accepted accounting principles and has not been audited. In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and revenues and expenses during the reporting periods. Actual results could differ from those estimates. Amounts requiring the use of significant estimates include the allowance for loan losses, valuation of deferred tax and servicing assets, the carrying value of loans held for sale and other real estate owned, the valuation of securities and the determination of other-than-temporary impairment for securities and fair value disclosures. Management believes that the allowance for loan losses is adequate. While management uses available information to recognize losses on loans, future additions to the allowance for loan losses may be necessary based on changes in economic conditions. The Company has evaluated subsequent events for potential recognition and/or disclosure through the date the Consolidated Financial Statements included in this Quarterly Report on Form 10-Q were available to be issued. The markets served by the Company have been significantly impacted by COVID-19, which started during the first quarter of 2020. The Company continues to assess the financial impact of the COVID-19 pandemic. The interim unaudited Consolidated Financial Statements included herein have been prepared in accordance with instructions for Form 10-Q and the rules and regulations of the Securities and Exchange Commission (“SEC”) and consist of normal recurring adjustments necessary for the fair presentation of interim results. The results of operations for the three months ended March 31, 2020 are not necessarily indicative of the results which may be expected for the entire year. As used in this Form 10-Q, “we” and “us” and “our” refer to Unity Bancorp, Inc., and its consolidated subsidiary, Unity Bank, depending on the context. Certain information and financial disclosures required by U.S. generally accepted accounting principles have been condensed or omitted from interim reporting pursuant to SEC rules. Interim financial statements should be read in conjunction with the Company’s Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 . Other-Than-Temporary Impairment The Company has a process in place to identify securities that could potentially incur credit impairment that is other-than-temporary. This process involves monitoring late payments, pricing levels, downgrades by rating agencies, key financial ratios, financial statements, revenue forecasts and cash flow projections as indicators of credit issues. Management evaluates securities for other-than-temporary impairment at least on a quarterly basis, and more frequently when economic or market concern warrants such evaluation. This evaluation considers relevant facts and circumstances in evaluating whether a credit or interest rate-related impairment of a security is other-than-temporary. Relevant facts and circumstances considered include: (1) the extent and length of time the fair value has been below cost; (2) the reasons for the decline in value; (3) the financial position and access to capital of the issuer, including the current and future impact of any specific events and (4) for fixed maturity securities, the intent to sell a security or whether it is more likely than not the Company will be required to sell the security before the recovery of its amortized cost which, in some cases, may extend to maturity and for equity securities, our ability and intent to hold the security for a forecasted period of time that allows for the recovery in value. Management assesses its intent to sell or whether it is more likely than not that it will be required to sell a security before recovery of its amortized cost basis less any current-period credit losses. For debt securities that are considered other-than-temporarily impaired with no intent to sell and no requirement to sell prior to recovery of its amortized cost basis, the amount of the impairment is separated into the amount that is credit related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between the security’s amortized cost basis and the present value of its expected future cash flows. The remaining difference between the security’s fair value and the present value of future expected cash flows is due to factors that are not credit related and is recognized in other comprehensive income. For debt securities where management has the intent to sell, the amount of the impairment is reflected in earnings as realized losses. The present value of expected future cash flows is determined using the best estimate cash flows discounted at the effective interest rate implicit to the security at the date of purchase or the current yield to accrete an asset-backed or floating rate security. The methodology and assumptions for establishing the best estimate cash flows vary depending on the type of security. The asset-backed securities cash flow estimates are based on bond specific facts and circumstances that may include collateral characteristics, expectations of delinquency and default rates, loss severity and prepayment speeds and structural support, including subordination and guarantees. The corporate bond cash flow estimates are derived from scenario-based outcomes of expected corporate restructurings or the disposition of assets using bond specific facts and circumstances including timing, security interests and loss severity. Transfers of Financial Assets Transfers of financial assets are accounted for as sales, when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when (1) the assets have been isolated from the Company, (2) the transferee obtains the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred assets, and (3) the Company does not maintain effective control over the transferred assets through an agreement to repurchase them before their maturity. Loans Loans Held for Sale Loans held for sale represent the guaranteed portion of Small Business Administration (“SBA”) loans and are reflected at the lower of aggregate cost or market value. The Company originates loans to customers under an SBA program that historically has provided for SBA guarantees of up to 90 percent of each loan. The Company generally sells the guaranteed portion of its SBA loans to a third party and retains the servicing, holding the nonguaranteed portion in its portfolio. The net amount of loan origination fees on loans sold is included in the carrying value and in the gain or loss on the sale. When sales of SBA loans do occur, the premium received on the sale and the present value of future cash flows of the servicing assets are recognized in income. All criteria for sale accounting must be met in order for the loan sales to occur; see details under the “Transfers of Financial Assets” heading above. Servicing assets represent the estimated fair value of retained servicing rights, net of servicing costs, at the time loans are sold. Servicing assets are amortized in proportion to, and over the period of, estimated net servicing revenues. Impairment is evaluated based on stratifying the underlying financial assets by date of origination and term. Fair value is determined using prices for similar assets with similar characteristics, when available, or based upon discounted cash flows using market-based assumptions. Any impairment, if temporary, would be reported as a valuation allowance. Serviced loans sold to others are not included in the accompanying Consolidated Balance Sheets. Income and fees collected for loan servicing are credited to noninterest income when earned, net of amortization on the related servicing assets. Loans Held to Maturity Loans held to maturity are stated at the unpaid principal balance, net of unearned discounts and deferred loan origination fees and costs. In accordance with the level yield method, loan origination fees, net of direct loan origination costs, are deferred and recognized over the estimated life of the related loans as an adjustment to the loan yield. Interest is credited to operations primarily based upon the principal balance outstanding. Loans are reported as past due when either interest or principal is unpaid in the following circumstances: fixed payment loans when the borrower is in arrears for two or more monthly payments; open end credit for two or more billing cycles; and single payment notes if interest or principal remains unpaid for 30 days or more. Nonperforming loans consist of loans that are not accruing interest as a result of principal or interest being in default for a period of 90 days or more or when the ability to collect principal and interest according to the contractual terms is in doubt (nonaccrual loans). When a loan is classified as nonaccrual, interest accruals are discontinued and all past due interest previously recognized as income is reversed and charged against current period earnings. Generally, until the loan becomes current, any payments received from the borrower are applied to outstanding principal until such time as management determines that the financial condition of the borrower and other factors merit recognition of a portion of such payments as interest income. Loans may be returned to an accrual status when the ability to collect is reasonably assured and when the loan is brought current as to principal and interest. Loans are charged off when collection is sufficiently questionable and when the Company can no longer justify maintaining the loan as an asset on the balance sheet. Loans qualify for charge-off when, after thorough analysis, all possible sources of repayment are insufficient. These include: 1) potential future cash flows, 2) value of collateral, and/or 3) strength of co-makers and guarantors. All unsecured loans are charged off upon the establishment of the loan’s nonaccrual status. Additionally, all loans classified as a loss or that portion of the loan classified as a loss is charged off. All loan charge-offs are approved by the Board of Directors. Troubled debt restructurings ("TDRs") occur when a creditor, for economic or legal reasons related to a debtor’s financial condition, grants a concession to the debtor that it would not otherwise consider. These concessions typically include reductions in interest rate, extending the maturity of a loan, or a combination of both. Interest income on accruing TDRs is credited to operations primarily based upon the principal amount outstanding, as stated in the paragraphs above. The Company evaluates its loans for impairment. A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan agreement. The Company has defined impaired loans to be all TDRs and nonperforming loans individually evaluated for impairment. Impairment is evaluated in total for smaller-balance loans of a similar nature (consumer and residential mortgage loans), and on an individual basis for all other loans. Impairment of a loan is measured based on the present value of expected future cash flows, discounted at the loan's effective interest rate, or as a practical expedient, based on a loan’s observable market price or the fair value of collateral, net of estimated costs to sell, if the loan is collateral-dependent. If the value of the impaired loan is less than the recorded investment in the loan, the Company establishes a valuation allowance, or adjusts existing valuation allowances, with a corresponding charge to the provision for loan losses. For additional information on loans, see Note 8 to the Consolidated Financial Statements and the section titled "Loan Portfolio" under Item 2. Management's Discussion and Analysis. Allowance for Loan Losses and Reserve for Unfunded Loan Commitments The allowance for loan losses is maintained at a level management considers adequate to provide for probable loan losses as of the balance sheet date. The allowance is increased by provisions charged to expense and is reduced by net charge-offs. The level of the allowance is based on management’s evaluation of probable losses in the loan portfolio, after consideration of prevailing economic conditions in the Company’s market area, the volume and composition of the loan portfolio, and historical loan loss experience. The allowance for loan losses consists of specific reserves for individually impaired credits and TDRs, reserves for nonimpaired loans based on historical loss factors and reserves based on general economic factors and other qualitative risk factors such as changes in delinquency trends, industry concentrations or local/national economic trends. This risk assessment process is performed at least quarterly, and, as adjustments become necessary, they are realized in the periods in which they become known. Although management attempts to maintain the allowance at a level deemed adequate to provide for probable losses, future additions to the allowance may be necessary based upon certain factors including changes in market conditions and underlying collateral values. In addition, various regulatory agencies periodically review the adequacy of the Company’s allowance for loan losses. These agencies may require the Company to make additional provisions based on their judgments about information available to them at the time of their examination. The Company maintains an allowance for unfunded loan commitments that is maintained at a level that management believes is adequate to absorb estimated probable losses. Adjustments to the allowance are made through other expenses and applied to the allowance which is maintained in other liabilities. For additional information on the allowance for loan losses and unfunded loan commitments, see Note 9 to the Consolidated Financial Statements and the sections titled "Asset Quality" and "Allowance for Loan Losses and Reserve for Unfunded Loan Commitments" under Item 2. Management's Discussion and Analysis. Income Taxes The Company accounts for income taxes according to the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using the enacted tax rates applicable to taxable income for the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation reserves are established against certain deferred tax assets when it is more likely than not that the deferred tax assets will not be realized. Increases or decreases in the valuation reserve are charged or credited to the income tax provision.When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that ultimately would be sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. The evaluation of a tax position taken is considered by itself and not offset or aggregated with other positions. Tax positions that meet the more likely than not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest and penalties associated with unrecognized tax benefits would be recognized in income tax expense on the income statement.

Litigation

Litigation	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Litigation	Litigation The Company may, in the ordinary course of business, become a party to litigation involving collection matters, contract claims and other legal proceedings relating to the conduct of its business. In the best judgment of management, based upon consultation with counsel, the consolidated financial position and results of operations of the Company will not be affected materially by the final outcome of any pending legal proceedings or other contingent liabilities and commitments.

Net Income per Share

Net Income per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Net Income per Share	Net Income per Share Basic net income per common share is calculated as net income divided by the weighted average common shares outstanding during the reporting period. Diluted net income per common share is computed similarly to that of basic net income per common share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if all potentially dilutive common shares, principally stock options, were issued during the reporting period utilizing the Treasury stock method. The following is a reconciliation of the calculation of basic and diluted income per share: For the three months ended March 31, (In thousands, except per share amounts) 2020 2019 Net income $ 5,368 $ 5,740 Weighted average common shares outstanding - Basic 10,883 10,801 Plus: Potential dilutive common stock equivalents 154 154 Weighted average common shares outstanding - Diluted 11,037 10,955 Net income per common share - Basic $ 0.49 $ 0.53 Net income per common share - Diluted 0.49 0.52 Stock options and common stock excluded from the income per share calculation as their effect would have been anti-dilutive 363 209

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company follows FASB ASC Topic 740, “Income Taxes,” which prescribes a threshold for the financial statement recognition of income taxes and provides criteria for the measurement of tax positions taken or expected to be taken in a tax return. ASC 740 also includes guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition of income taxes. On July 1, 2018, New Jersey's Assembly Bill 4202 was signed into law. The bill, effective January 1, 2018, imposes a temporary surtax on corporations earning New Jersey allocated taxable income in excess of $1 million at a rate of 2.5 percent for tax years beginning on or after January 1, 2018, through December 31, 2019, and at 1.5 percent for tax years beginning on or after January 1, 2020, through December 31, 2021. In addition, New Jersey adopted mandatory unitary combined reporting for its Corporation Business Tax, which became effective for periods on or after January 1, 2019. For the quarter ended March 31, 2020 , the Company reported income tax expense of $1.6 million for an effective tax rate of 22.9 percent, compared to an income tax expense of $1.5 million and an effective tax rate of 20.9 percent for the prior year’s quarter. The Company did not recognize or accrue any interest or penalties related to income taxes during the three months ended March 31, 2020 or 2019 . The Company did not have an accrual for uncertain tax positions as of March 31, 2020 or December 31, 2019 , as deductions taken and benefits accrued are based on widely understood administrative practices and procedures and are based on clear and unambiguous tax law. Tax returns for all years 2015 and thereafter are subject to future examination by tax authorities.

Other Comprehensive Income (Los

Other Comprehensive Income (Loss)	3 Months Ended
	Mar. 31, 2020
Stockholders' Equity Note [Abstract]
Other Comprehensive Income (Loss)	Other Comprehensive Income (Loss) The following tables show the changes in other comprehensive income (loss) for the three months ended March 31, 2020 and 2019 , net of tax: For the three months ended March 31, 2020 (In thousands) Net unrealized gains (losses) on securities Adjustments related to defined benefit plan Net unrealized gains (losses) from cash flow hedges Accumulated other comprehensive income (loss) Balance, beginning of period (1) $ 316 $ (295 ) $ 168 $ 189 Other comprehensive loss before reclassifications (131 ) — (1,004 ) (1,135 ) Less amounts reclassified from accumulated other comprehensive loss (134 ) (15 ) — (149 ) Period change 3 15 (1,004 ) (986 ) Balance, end of period (1) $ 319 $ (280 ) $ (836 ) $ (797 ) For the three months ended March 31, 2019 (In thousands) Net unrealized (losses) gains on securities Adjustments related to defined benefit plan Net unrealized gains (losses) from cash flow hedges Accumulated other comprehensive loss Balance, beginning of period (1) $ (721 ) $ (431 ) $ 1,030 $ (122 ) Other comprehensive income (loss) before reclassifications 240 — (302 ) (62 ) Less amounts reclassified from accumulated other comprehensive income (loss) 79 (91 ) — (12 ) Period change 161 91 (302 ) (50 ) Balance, end of period (1) $ (560 ) $ (340 ) $ 728 $ (172 ) (1) AOCI does not reflect the net reclassification of $35 thousand to Retained Earnings as a result of ASU 2016-01, "Financial Instruments Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities" & ASU 2018-02, "Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income".

Fair Value

Fair Value	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value	Fair Value Fair Value Measurement The Company follows FASB ASC Topic 820, “Fair Value Measurement and Disclosures,” which requires additional disclosures about the Company’s assets and liabilities that are measured at fair value. Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In determining fair value, the Company uses various methods including market, income and cost approaches. Based on these approaches, the Company often utilizes certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and/or the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable inputs. The Company utilizes techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy ranks the quality and reliability of the information used to determine fair values. Financial assets and liabilities carried at fair value will be classified and disclosed as follows: Level 1 Inputs • Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. • Generally, this includes debt and equity securities and derivative contracts that are traded in an active exchange market (i.e. New York Stock Exchange), as well as certain U.S. Treasury, U.S. Government and sponsored entity agency mortgage-backed securities that are highly liquid and are actively traded in over-the-counter markets. Level 2 Inputs • Quoted prices for similar assets or liabilities in active markets. • Quoted prices for identical or similar assets or liabilities in inactive markets. • Inputs other than quoted prices that are observable, either directly or indirectly, for the term of the asset or liability (i.e., interest rates, yield curves, credit risks, prepayment speeds or volatilities) or “market corroborated inputs.” • Generally, this includes U.S. Government and sponsored entity mortgage-backed securities, corporate debt securities and derivative contracts. Level 3 Inputs • Prices or valuation techniques that require inputs that are both unobservable (i.e. supported by little or no market activity) and that are significant to the fair value of the assets or liabilities. • These assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. Fair Value on a Recurring Basis The following is a description of the valuation methodologies used for instruments measured at fair value on a recurring basis: Debt Securities Available for Sale The fair value of available for sale ("AFS") debt securities is the market value based on quoted market prices, when available, or market prices provided by recognized broker dealers (Level 1). If listed prices or quotes are not available, fair value is based upon quoted market prices for similar or identical assets or other observable inputs (Level 2) or externally developed models that use unobservable inputs due to limited or no market activity of the instrument (Level 3). As of March 31, 2020 , the fair value of the Company's AFS debt securities portfolio was $56.3 million . Approximately 42 percent of the portfolio was made up of residential mortgage-backed securities, which had a fair value of $23.9 million at March 31, 2020 . Approximately $23.6 million of the residential mortgage-backed securities are guaranteed by the Government National Mortgage Association ("GNMA"), the Federal National Mortgage Association ("FNMA") or the Federal Home Loan Mortgage Corporation ("FHLMC"). The underlying loans for these securities are residential mortgages that are geographically dispersed throughout the United States. All of the Company’s AFS debt securities were classified as Level 2 assets at March 31, 2020 . The valuation of AFS debt securities using Level 2 inputs was primarily determined using the market approach, which uses quoted prices for similar assets or liabilities in active markets and all other relevant information. It includes model pricing, defined as valuing securities based upon their relationship with other benchmark securities. Equity Securities with Readily Determinable Fair Values The fair value of equity securities is the market value based on quoted market prices, when available, or market prices provided by recognized broker dealers (Level 1). If listed prices or quotes are not available, fair value is based upon quoted market prices for similar or identical assets or other observable inputs (Level 2) or externally developed models that use unobservable inputs due to limited or no market activity of the instrument (Level 3). As of March 31, 2020 , the fair value of the Company's equity securities portfolio was $1.7 million . All of the Company’s equity securities were classified as Level 2 assets at March 31, 2020 . The valuation of equity securities using Level 2 inputs was primarily determined using the market approach, which uses quoted prices for similar assets or liabilities in active markets and all other relevant information. There were no changes in the inputs or methodologies used to determine fair value during the period ended March 31, 2020 , as compared to the periods ended December 31, 2019 and March 31, 2019 . Loans Held for Sale Fair Value for loans held for sale is derived from quoted market prices for similar loans, in which case they are characterized as Level 2 assets in the fair value hierarchy. Interest Rate Swap Agreements The fair value of interest rate swap agreements is the market value based on quoted market prices, when available, or market prices provided by recognized broker dealers (Level 1). If listed prices or quotes are not available, fair value is based upon quoted market prices for similar or identical assets or other observable inputs (Level 2) or externally developed models that use unobservable inputs due to limited or no market activity of the instrument (Level 3). The Company's derivative instruments are classified as Level 2 assets, as the readily observable market inputs to these models are validated to external sources, such as industry pricing services, or are corroborated through recent trades, dealer quotes, yield curves, implied volatility or other market-related data. The tables below present the balances of assets and liabilities measured at fair value on a recurring basis as of March 31, 2020 and December 31, 2019 : Fair Value Measurements at March 31, 2020 Using (In thousands) Assets/Liabilities Measured at Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Measured on a recurring basis: Assets: Debt securities available for sale: U.S. Government sponsored entities $ 5,781 $ — $ 5,781 $ — State and political subdivisions 3,439 — 3,439 — Residential mortgage-backed securities 23,850 — 23,850 — Corporate and other securities 23,220 — 23,220 — Total debt securities available for sale $ 56,290 $ — $ 56,290 $ — Equity securities with readily determinable fair values 1,712 — 1,712 — Total equity securities $ 1,712 $ — $ 1,712 $ — Loans held for sale 11,658 — 11,658 — Total loans held for sale $ 11,658 — $ 11,658 — Interest rate swap agreements (1,173 ) — (1,173 ) — Total swap agreements $ (1,173 ) $ — $ (1,173 ) $ — Fair value Measurements at December 31, 2019 Using (In thousands) Assets/Liabilities Measured at Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Measured on a recurring basis: Assets: Debt securities available for sale: U.S. Government sponsored entities $ 5,753 $ — $ 5,753 $ — State and political subdivisions 5,154 — 5,154 — Residential mortgage-backed securities 27,964 — 27,964 — Corporate and other securities 25,404 — 25,404 — Total debt securities available for sale $ 64,275 $ — $ 64,275 $ — Equity securities with readily determinable fair values 2,289 — 2,289 — Total equity securities $ 2,289 $ — $ 2,289 $ — Loans held for sale 14,862 14,862 Total loans held for sale $ 14,862 $ 14,862 Interest rate swap agreements 238 — 238 — Total swap agreements $ 238 $ — $ 238 $ — Fair Value on a Nonrecurring Basis The following tables present the assets and liabilities subject to fair value adjustments (impairment) on a non-recurring basis carried on the balance sheet by caption and by level within the hierarchy (as described above): Fair Value Measurements at March 31, 2020 Using (In thousands) Assets/Liabilities Measured at Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Net Credit During Period Measured on a non-recurring basis: Financial assets: OREO $ 1,523 $ — $ — $ 1,523 $ (200 ) Impaired collateral-dependent loans 2,323 — — 2,323 (230 ) Fair Value Measurements at December 31, 2019 Using (In thousands) Assets/Liabilities Measured at Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Net Credit During Period Financial assets: OREO $ 1,723 $ — $ — $ 1,723 $ (231 ) Impaired collateral-dependent loans 1,925 — — 1,925 (253 ) Certain assets and liabilities are not measured at fair value on an ongoing basis but are subject to fair value adjustments in certain circumstances (for example, when there is evidence of impairment). The following is a description of the valuation methodologies used for instruments measured at fair value on a nonrecurring basis: Appraisal Policy All appraisals must be performed in accordance with the Uniform Standards of Professional Appraisal Practice ("USPAP"). Appraisals are certified to the Company and performed by appraisers on the Company’s approved list of appraisers. Evaluations are completed by a person independent of Company management. The content of the appraisal depends on the complexity of the property. Appraisals are completed on a “retail value” and an “as is value.” OREO The fair value of OREO is determined using third party appraisals, which may be discounted based on management’s review and changes in market conditions (Level 3 Inputs). Impaired Collateral-Dependent Loans The fair value of impaired collateral-dependent loans is derived in accordance with FASB ASC Topic 310, “Receivables.” Fair value is determined based on the loan’s observable market price or the fair value of the collateral. Partially charged-off loans are measured for impairment based upon a third party appraisal for collateral-dependent loans. When an updated appraisal is received for a nonperforming loan, the value on the appraisal is discounted in the manner discussed above. If there is a deficiency in the value after the Company applies these discounts, management applies a specific reserve and the loan remains in nonaccrual status. The receipt of an updated appraisal would not qualify as a reason to put a loan back into accruing status. The Company removes loans from nonaccrual status generally when the borrower makes three months of contractual payments and demonstrates the ability to service the debt going forward. Charge-offs are determined based upon the loss that management believes the Company will incur after evaluating collateral for impairment based upon the valuation methods described above and the ability of the borrower to pay any deficiency. The valuation allowance for impaired loans is included in the allowance for loan losses in the consolidated balance sheets. At March 31, 2020 , the valuation allowance for impaired loans was $184 thousand , a decrease of $230 thousand from $414 thousand at December 31, 2019 . Fair Value of Financial Instruments FASB ASC Topic 825, “Financial Instruments,” requires the disclosure of the estimated fair value of certain financial instruments, including those financial instruments for which the Company did not elect the fair value option. These estimated fair values as of March 31, 2020 and December 31, 2019 have been determined using available market information and appropriate valuation methodologies. Considerable judgment is required to interpret market data to develop estimates of fair value. The estimates presented are not necessarily indicative of amounts the Company could realize in a current market exchange. The use of alternative market assumptions and estimation methodologies could have had a material effect on these estimates of fair value. The methodology for estimating the fair value of financial assets and liabilities that are measured on a recurring or nonrecurring basis are discussed above. The following methods and assumptions were used to estimate the fair value of other financial instruments for which it is practicable to estimate that value: Cash and Cash Equivalents For these short-term instruments, the carrying value is a reasonable estimate of fair value. Securities The fair value of securities is based upon quoted market prices for similar or identical assets or other observable inputs (Level 2) or externally developed models that use unobservable inputs due to limited or no market activity of the instrument (Level 3). SBA Loans Held for Sale The fair value of SBA loans held for sale is estimated by using a market approach that includes significant other observable inputs. Loans The fair value of loans is estimated by discounting the future cash flows using current market rates that reflect the interest rate risk inherent in the loan, except for previously discussed impaired loans. FHLB Stock Federal Home Loan Bank stock is carried at cost. Carrying value approximates fair value based on the redemption provisions of the issues. Servicing Assets Servicing assets do not trade in an active, open market with readily observable prices. The Company estimates the fair value of servicing assets using discounted cash flow models incorporating numerous assumptions from the perspective of a market participant including market discount rates and prepayment speeds. Accrued Interest The carrying amounts of accrued interest approximate fair value. Deposit Liabilities The fair value of demand deposits and savings accounts is the amount payable on demand at the reporting date (i.e. carrying value). The fair value of fixed-maturity certificates of deposit is estimated by discounting the future cash flows using current market rates. Borrowed Funds and Subordinated Debentures The fair value of borrowings is estimated by discounting the projected future cash flows using current market rates. Standby Letters of Credit At March 31, 2020 , the Bank had standby letters of credit outstanding of $4.9 million , compared to $4.8 million at December 31, 2019 . The fair value of these commitments is nominal. The table below presents the carrying amount and estimated fair values of the Company’s financial instruments presented as of March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 (In thousands) Fair value level Carrying amount Estimated fair value Carrying amount Estimated fair value Financial assets: Cash and cash equivalents Level 1 $ 178,995 $ 178,995 $ 158,016 $ 158,016 Securities Level 2 58,002 58,002 66,564 66,564 SBA loans held for sale Level 2 10,726 11,658 13,529 14,862 Loans, net of allowance for loan losses (1) Level 2 1,411,543 1,427,787 1,395,634 1,398,997 FHLB stock Level 2 9,054 9,054 14,184 14,184 Servicing assets Level 3 2,138 2,138 2,026 2,026 Accrued interest receivable Level 2 7,396 7,396 6,984 6,984 OREO Level 3 1,523 1,523 1,723 1,723 Financial liabilities: Deposits Level 2 1,378,618 1,385,200 1,250,114 1,252,082 Borrowed funds and subordinated debentures Level 2 179,310 180,911 293,310 292,766 Accrued interest payable Level 2 237 237 455 455 (1) Includes collateral-dependent impaired loans that are considered Level 3 and reported separately in the tables under the “Fair Value on a Nonrecurring Basis” heading. Collateral-dependent impaired loans, net of specific reserves totaled $2.3 million and $1.9 million at March 31, 2020 and December 31, 2019 , respectively. Limitations Fair value estimates are made at a point in time, based on relevant market information and information about the financial instrument. These estimates do not reflect any premium or discount that could result from offering for sale at one time the Company's entire holdings of a particular financial instrument. Because no market exists for a significant portion of the Company's financial instruments, fair value estimates are based on judgments regarding future expected loss experience, current economic conditions, risk characteristics of various financial instruments and other factors. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates. Fair value estimates are based on existing on- and off-statement of condition financial instruments without attempting to estimate the value of anticipated future business and the value of assets and liabilities that are not considered financial instruments. In addition, the tax ramifications related to the effect of fair value estimates have not been considered in the above estimates.

Securities

Securities	3 Months Ended
	Mar. 31, 2020
Marketable Securities [Abstract]
Securities	Securities This table provides the major components of debt securities available for sale ("AFS") and equity securities with readily determinable fair values ("equity securities") at amortized cost and estimated fair value at March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 (In thousands) Amortized cost Gross unrealized gains Gross unrealized losses Estimated fair value Amortized cost Gross unrealized gains Gross unrealized losses Estimated fair value Available for sale: U.S. Government sponsored entities $ 5,749 $ 32 $ — $ 5,781 $ 5,751 $ 4 $ (2 ) $ 5,753 State and political subdivisions 3,581 7 (149 ) 3,439 4,992 174 (12 ) 5,154 Residential mortgage-backed securities 23,293 639 (82 ) 23,850 27,698 372 (106 ) 27,964 Corporate and other securities 23,271 235 (286 ) 23,220 25,442 230 (268 ) 25,404 Total debt securities available for sale $ 55,894 $ 913 $ (517 ) $ 56,290 $ 63,883 $ 780 $ (388 ) $ 64,275 Equity securities: Total equity securities $ 2,112 $ — $ (400 ) $ 1,712 $ 2,218 $ 142 $ (71 ) $ 2,289 This table provides the remaining contractual maturities and yields of securities within the investment portfolios. The carrying value of securities at March 31, 2020 is distributed by contractual maturity. Mortgage-backed securities and other securities, which may have principal prepayment provisions, are distributed based on contractual maturity. Expected maturities will differ materially from contractual maturities as a result of early prepayments and calls. Within one year After one through five years After five through ten years After ten years Total carrying value (In thousands, except percentages) Amount Yield Amount Yield Amount Yield Amount Yield Amount Yield Available for sale at fair value: U.S. Government sponsored entities $ 3,776 1.61 % $ 2,005 2.16 % $ — — % $ — — % $ 5,781 1.80 % State and political subdivisions 195 3.80 600 3.92 1,748 3.16 896 2.74 3,439 3.22 Residential mortgage-backed securities 2 4.76 322 2.35 2,331 2.48 21,195 2.80 23,850 2.76 Corporate and other securities — — 1,610 3.49 16,371 4.77 5,239 4.87 23,220 4.70 Total debt securities available for sale $ 3,973 1.72 % $ 4,537 2.88 % $ 20,450 4.37 % $ 27,330 3.19 % $ 56,290 3.49 % Equity Securities at fair value: Total equity securities $ — — % $ — — % $ — — % $ 1,712 2.72 % $ 1,712 2.72 % The fair value of securities with unrealized losses by length of time that the individual securities have been in a continuous unrealized loss position at March 31, 2020 and December 31, 2019 are as follows: March 31, 2020 Less than 12 months 12 months and greater Total (In thousands, except number in a loss position) Total number in a loss position Estimated fair value Unrealized loss Estimated fair value Unrealized loss Estimated fair value Unrealized loss Available for sale: State and political subdivisions 3 $ 1,246 $ (109 ) $ 896 $ (40 ) $ 2,142 $ (149 ) Residential mortgage-backed securities 7 2,526 (12 ) 3,042 (70 ) 5,568 (82 ) Corporate and other securities 6 3,311 (55 ) 3,758 (231 ) 7,069 (286 ) Total temporarily impaired securities 16 $ 7,083 $ (176 ) $ 7,696 $ (341 ) $ 14,779 $ (517 ) December 31, 2019 Less than 12 months 12 months and greater Total (In thousands, except number in a loss position) Total number in a loss position Estimated fair value Unrealized loss Estimated fair value Unrealized loss Estimated fair value Unrealized loss Available for sale: U.S. Government sponsored entities 1 $ — $ — $ 1,995 $ (2 ) $ 1,995 $ (2 ) State and political subdivisions 1 — — 1,013 (12 ) 1,013 (12 ) Residential mortgage-backed securities 10 3,707 (27 ) 4,996 (79 ) 8,703 (106 ) Corporate and other securities 6 3,366 (13 ) 3,735 (255 ) 7,101 (268 ) Total temporarily impaired securities 18 $ 7,073 $ (40 ) $ 11,739 $ (348 ) $ 18,812 $ (388 ) Unrealized Losses The unrealized losses in each of the categories presented in the tables above are discussed in the paragraphs that follow: U.S. government sponsored entities and state and political subdivision securities: The unrealized losses on investments in these types of securities were caused by the increase in interest rate spreads or the increase in interest rates at the long end of the Treasury curve. The contractual terms of these investments do not permit the issuer to settle the securities at a price less than the par value of the investments. Because the Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be at maturity, the Company did not consider these investments to be other-than temporarily impaired as of March 31, 2020 or December 31, 2019 . Residential and commercial mortgage-backed securities: The unrealized losses on investments in mortgage-backed securities were caused by increases in interest rate spreads or the increase in interest rates at the long end of the Treasury curve. The majority of contractual cash flows of these securities are guaranteed by the Federal National Mortgage Association (FNMA), the Government National Mortgage Association (GNMA) or the Federal Home Loan Mortgage Corporation (FHLMC). It is expected that the securities would not be settled at a price significantly less than the par value of the investment. Because the decline in fair value is attributable to changes in interest rates and not credit quality, and because the Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be at maturity, the Company did not consider these investments to be other-than-temporarily impaired as of March 31, 2020 or December 31, 2019 . Corporate and other securities: Included in this category are corporate and other debt securities. The unrealized losses on corporate and other debt securities were due to widening credit spreads. The Company evaluated the prospects of the issuers and forecasted a recovery period; and as a result determined it did not consider these investments to be other-than-temporarily impaired as of March 31, 2020 or December 31, 2019 . Because the Company does not intend to sell the securities and it is not more likely than not that the Company will be required to sell the securities before recovery of its amortized cost basis, which may be at maturity, the Company did not consider these securities to be other-than-temporarily impaired as of March 31, 2020 or December 31, 2019 . Realized Gains and Losses Gross realized gains and losses on securities for the three months ended March 31, 2020 and 2019 are detailed in the table below: For the three months ended March 31, (In thousands) 2020 2019 Available for sale: Realized gains $ 296 $ — Realized losses — — Total debt securities available for sale 296 — Net gains on sales of securities $ 296 $ — The net realized gains are included in noninterest income in the Consolidated Statements of Income as net security gains. There were $296 thousand of gross realized gains during the three months ended March 31, 2020, compared to no gross realized gains during the same period a year ago. There were no gross realized losses for the three months ended March 31, 2020, or 2019. • The net gain during the first quarter of 2020 is attributed to the sale of one corporate bond with a book value of $2.2 million and resulting gains of $61 thousand , three mortgage-backed securities with a total book value of $2.8 million and resulting gains of $57 thousand , one tax-exempt municipal security with a book value of $381 thousand and resulting gains of $27 thousand , one taxable municipal security with a book value of $456 thousand and resulting gains of $140 thousand , and the call of one tax-exempt municipal security with a book value of $485 thousand and resulting gains of $11 thousand . Equity Securities Included in this category are Community Reinvestment Act ("CRA") investments and the Company's current other equity holdings of financial institutions. Equity securities are defined to include (a) preferred, common and other ownership interests in entities including partnerships, joint ventures and limited liability companies and (b) rights to acquire or dispose of ownership interest in entities at fixed or determinable prices. The Company follows ASU 2016-01, "Financial Instruments - Overall (Subtopic 825-10) - Recognition and Measurement of Financial Assets and Financial Liabilities," which aims to simplify accounting for financial instruments and to converge the guidance between U.S. GAAP and IFRS. ASU 2016-01 also includes guidance on how entities account for equity investments, present and disclose financial instruments, and measure the valuation allowance on deferred tax assets related to available-for-sale debt securities. The guidance in ASU 2016-01 requires an entity to disaggregate the net gains and losses on the equity investments recognized in the income statement during a reporting period into realized and unrealized gains and losses. As a result, equity securities are no longer carried at fair value through other comprehensive income ("OCI") or by applying the cost method to those equity securities that do not have readily determinable values. Equity securities are generally required to be measured at fair value with market value adjustments being reflected in net income. The Company adopted this standard as of January 1, 2018. The following is a summary of unrealized and realized gains and losses recognized in net income on equity securities during the three months ended March 31, 2020 and 2019: For the three months ended March 31, (In thousands) 2020 2019 Net (losses) gains recognized during the period on equity securities $ (471 ) $ 100 Net gains recognized during the period on equity securities sold during the period 5 — Unrealized (losses) gains recognized during the reporting period on equity securities still held at the reporting date $ (466 ) $ 100 Pledged Securities Securities with a carrying value of $3.5 million and $4.0 million for March 31, 2020 and December 31, 2019 , respectively, were pledged to secure Government deposits, secure other borrowings and for other purposes required or permitted by law.

Loans

Loans	3 Months Ended
	Mar. 31, 2020
Loans and Leases Receivable Disclosure [Abstract]
Loans	Loans The following table sets forth the classification of loans by class, including unearned fees, deferred costs and excluding the allowance for loan losses as of March 31, 2020 and December 31, 2019 : (In thousands) March 31, 2020 December 31, 2019 SBA loans held for investment $ 37,074 $ 35,767 Commercial loans SBA 504 loans 25,185 26,726 Commercial other 120,029 112,014 Commercial real estate 586,336 578,643 Commercial real estate construction 54,528 47,649 Residential mortgage loans 456,072 467,706 Consumer loans Home equity 75,240 69,589 Consumer other 74,455 73,935 Total loans held for investment $ 1,428,919 $ 1,412,029 SBA loans held for sale 10,726 13,529 Total loans $ 1,439,645 $ 1,425,558 Loans are made to individuals as well as commercial entities. Specific loan terms vary as to interest rate, repayment, and collateral requirements based on the type of loan requested and the credit worthiness of the prospective borrower. Credit risk tends to be geographically concentrated in that a majority of the loan customers are located in the markets serviced by the Bank. Loan performance may be adversely affected by factors impacting the general economy or conditions specific to the real estate market such as geographic location and/or property type. A description of the Company's different loan segments follows: SBA Loans: SBA 7 (a) loans, on which the SBA has historically provided guarantees of up to 90 percent of the principal balance, are considered a higher risk loan product for the Company than its other loan products. The guaranteed portion of the Company’s SBA loans is generally sold in the secondary market with the nonguaranteed portion held in the portfolio as a loan held for investment. SBA loans are for the purpose of providing working capital, financing the purchase of equipment, inventory or commercial real estate and for other business purposes. Loans are guaranteed by the businesses' major owners. SBA loans are made based primarily on the historical and projected cash flow of the business and secondarily on the underlying collateral provided. Commercial Loans: Commercial credit is extended primarily to middle market and small business customers. Commercial loans are generally made in the Company’s market place for the purpose of providing working capital, financing the purchase of equipment, inventory or commercial real estate and for other business purposes. The SBA 504 program consists of real estate backed commercial mortgages where the Company has the first mortgage and the SBA has the second mortgage on the property. Loans will generally be guaranteed in full or for a meaningful amount by the businesses' major owners. Commercial loans are made based primarily on the historical and projected cash flow of the business and secondarily on the underlying collateral provided. Generally, the Company has a 50 percent loan to value ratio on SBA 504 program loans at origination. Residential Mortgage and Consumer Loans: The Company originates mortgage and consumer loans including principally residential real estate and home equity lines and loans and consumer construction lines. The Company originates qualified mortgages which are generally sold in the secondary market and nonqualified mortgages which are generally held for investment. Each loan type is evaluated on debt to income, type of collateral and loan to collateral value, credit history and Company’s relationship with the borrower. Inherent in the lending function is credit risk, which is the possibility a borrower may not perform in accordance with the contractual terms of their loan. A borrower’s inability to pay their obligations according to the contractual terms can create the risk of past due loans and, ultimately, credit losses, especially on collateral deficient loans. The Company minimizes its credit risk by loan diversification and adhering to credit administration policies and procedures. Due diligence on loans begins when we initiate contact regarding a loan with a borrower. Documentation, including a borrower’s credit history, materials establishing the value and liquidity of potential collateral, the purpose of the loan, the source of funds for repayment of the loan, and other factors, are analyzed before a loan is submitted for approval. The loan portfolio is then subject to on-going internal reviews for credit quality which in part is derived from ongoing collection and review of borrowers’ financial information, as well as independent credit reviews by an outside firm. The Company's extension of credit is governed by the Credit Risk Policy which was established to control the quality of the Company's loans. This policy and the underlying procedures are reviewed and approved by the Board of Directors on a regular basis. Credit Ratings For SBA 7(a), SBA 504 and commercial loans, management uses internally assigned risk ratings as the best indicator of credit quality. A loan’s internal risk rating is updated at least annually and more frequently if circumstances warrant a change in risk rating. The Company uses a 1 through 10 loan grading system that follows regulatory accepted definitions. Pass: Risk ratings of 1 through 6 are used for loans that are performing, as they meet, and are expected to continue to meet, all of the terms and conditions set forth in the original loan documentation, and are generally current on principal and interest payments. These performing loans are termed “Pass”. Special Mention: Criticized loans are assigned a risk rating of 7 and termed “Special Mention”, as the borrowers exhibit potential credit weaknesses or downward trends deserving management’s close attention. If not checked or corrected, these trends will weaken the Bank’s collateral and position. While potentially weak, these borrowers are currently marginally acceptable and no loss of interest or principal is anticipated. As a result, special mention assets do not expose an institution to sufficient risk to warrant adverse classification. Included in “Special Mention” could be turnaround situations, such as borrowers with deteriorating trends beyond one year, borrowers in startup or deteriorating industries, or borrowers with a poor market share in an average industry. "Special Mention" loans may include an element of asset quality, financial flexibility, or below average management. Management and ownership may have limited depth or experience. Regulatory agencies have agreed on a consistent definition of “Special Mention” as an asset with potential weaknesses which, if left uncorrected, may result in deterioration of the repayment prospects for the asset or in the Bank’s credit position at some future date. This definition is intended to ensure that the “Special Mention” category is not used to identify assets that have as their sole weakness credit data exceptions or collateral documentation exceptions that are not material to the repayment of the asset. Substandard: Classified loans are assigned a risk rating of an 8 or 9, depending upon the prospect for collection, and deemed “Substandard”. A risk rating of 8 is used for borrowers with well-defined weaknesses that jeopardize the orderly liquidation of debt. The loan is inadequately protected by the current paying capacity of the obligor or by the collateral pledged, if any. Normal repayment from the borrower is in jeopardy, although no loss of principal is envisioned. There is a distinct possibility that a partial loss of interest and/or principal will occur if the deficiencies are not corrected. Loss potential, while existing in the aggregate amount of substandard assets, does not have to exist in individual assets classified “Substandard”. A risk rating of 9 is used for borrowers that have all the weaknesses inherent in a loan with a risk rating of 8, with the added characteristic that the weaknesses make collection of debt in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable. Serious problems exist to the point where partial loss of principal is likely. The possibility of loss is extremely high, but because of certain important, reasonably specific pending factors that may work to strengthen the assets, the loans’ classification as estimated losses is deferred until a more exact status may be determined. Pending factors include proposed merger, acquisition, or liquidation procedures; capital injection; perfecting liens on additional collateral; and refinancing plans. Partial charge-offs are likely. Loss: Once a borrower is deemed incapable of repayment of unsecured debt, the risk rating becomes a 10, the loan is termed a “Loss”, and charged-off immediately. Loans to such borrowers are considered uncollectible and of such little value that continuance as active assets of the Bank is not warranted. This classification does not mean that the loan has absolutely no recovery or salvage value, but rather it is not practical or desirable to defer writing off these basically worthless assets even though partial recovery may be affected in the future. For residential mortgage and consumer loans, management uses performing versus nonperforming as the best indicator of credit quality. Nonperforming loans consist of loans that are not accruing interest (nonaccrual loans) as a result of principal or interest being in default for a period of 90 days or more or when the ability to collect principal and interest according to the contractual terms is in doubt. These credit quality indicators are updated on an ongoing basis, as a loan is placed on nonaccrual status as soon as management believes there is sufficient doubt as to the ultimate ability to collect interest on a loan. At March 31, 2020 , the Company owned $1.5 million in residential consumer properties that were included in OREO in the Consolidated Balance Sheets, compared to $1.7 million at December 31, 2019 . Additionally, there were $4.3 million of residential consumer loans in the process of foreclosure at March 31, 2020 , compared to $3.6 million at December 31, 2019 . The tables below detail the Company’s loan portfolio by class according to their credit quality indicators discussed in the paragraphs above as of March 31, 2020 : March 31, 2020 SBA, SBA 504 & Commercial loans - Internal risk ratings (In thousands) Pass Special mention Substandard Total SBA loans held for investment $ 35,994 $ — $ 1,080 $ 37,074 Commercial loans SBA 504 loans 23,374 1,779 32 25,185 Commercial other 114,840 3,525 1,664 120,029 Commercial real estate 584,044 749 1,543 586,336 Commercial real estate construction 54,528 — — 54,528 Total commercial loans 776,786 6,053 3,239 786,078 Total SBA, SBA 504 and commercial loans $ 812,780 $ 6,053 $ 4,319 $ 823,152 Residential mortgage & Consumer loans - Performing/Nonperforming (In thousands) Performing Nonperforming Total Residential mortgage loans $ 449,162 $ 6,910 $ 456,072 Consumer loans Home equity 74,735 505 75,240 Consumer other 74,455 — 74,455 Total consumer loans 149,190 505 149,695 Total residential mortgage and consumer loans $ 598,352 $ 7,415 $ 605,767 The tables below detail the Company’s loan portfolio by class according to their credit quality indicators discussed in the paragraphs above as of December 31, 2019 : December 31, 2019 SBA, SBA 504 & Commercial loans - Internal risk ratings (In thousands) Pass Special mention Substandard Total SBA loans held for investment $ 34,202 $ 1,115 $ 450 $ 35,767 Commercial loans SBA 504 loans 24,878 1,808 40 26,726 Commercial other 107,220 3,361 1,433 112,014 Commercial real estate 576,326 758 1,559 578,643 Commercial real estate construction 47,649 — — 47,649 Total commercial loans 756,073 5,927 3,032 765,032 Total SBA, SBA 504 and commercial loans $ 790,275 $ 7,042 $ 3,482 $ 800,799 Residential mortgage & Consumer loans - Performing/Nonperforming (In thousands) Performing Nonperforming Total Residential mortgage loans $ 463,770 $ 3,936 $ 467,706 Consumer loans Home equity 69,589 — 69,589 Consumer other 73,915 20 73,935 Total consumer loans 143,504 20 143,524 Total residential mortgage and consumer loans $ 607,274 $ 3,956 $ 611,230 Nonperforming and Past Due Loans Nonperforming loans consist of loans that are not accruing interest (nonaccrual loans) as a result of principal or interest being in default for a period of 90 days or more or when the ability to collect principal and interest according to the contractual terms is in doubt. Loans past due 90 days or more and still accruing interest are not included in nonperforming loans and generally represent loans that are well collateralized and in the process of collection. The risk of loss is difficult to quantify and is subject to fluctuations in collateral values, general economic conditions and other factors. The Company values its collateral through the use of appraisals, broker price opinions, and knowledge of its local market. The following tables set forth an aging analysis of past due and nonaccrual loans as of March 31, 2020 and December 31, 2019 : March 31, 2020 (In thousands) 30-59 days past due 60-89 days past due 90+ days and still accruing Nonaccrual (1) Total past due Current Total loans SBA loans held for investment $ 131 $ 154 $ — $ 1,627 $ 1,912 $ 35,162 $ 37,074 Commercial loans SBA 504 loans — — — — — 25,185 25,185 Commercial other 566 71 — — 637 119,392 120,029 Commercial real estate 785 75 — 613 1,473 584,863 586,336 Commercial real estate construction — — — — — 54,528 54,528 Residential mortgage loans 5,880 373 — 6,910 13,163 442,909 456,072 Consumer loans Home equity 561 329 — 505 1,395 73,845 75,240 Consumer other — — — — — 74,455 74,455 Total loans held for investment $ 7,923 $ 1,002 $ — $ 9,655 $ 18,580 $ 1,410,339 $ 1,428,919 SBA loans held for sale — — — — — 10,726 10,726 Total loans $ 7,923 $ 1,002 $ — $ 9,655 $ 18,580 $ 1,421,065 $ 1,439,645 (1) At March 31, 2020 , nonaccrual loans included $427 thousand of loans guaranteed by the SBA. December 31, 2019 (In thousands) 30-59 days past due 60-89 days past due 90+ days and still accruing Nonaccrual (1) Total past due Current Total loans SBA loans held for investment $ 1,048 $ — $ — $ 1,164 $ 2,212 $ 33,555 $ 35,767 Commercial loans SBA 504 loans — 1,808 — — 1,808 24,918 26,726 Commercial other 71 — — 316 387 111,627 112,014 Commercial real estate 215 — — 213 428 578,215 578,643 Commercial real estate construction — — — — — 47,649 47,649 Residential mortgage loans 4,383 1,676 930 3,936 10,925 456,781 467,706 Consumer loans Home equity 1,446 178 — — 1,624 67,965 69,589 Consumer other — 113 — 20 133 73,802 73,935 Total loans held for investment $ 7,163 $ 3,775 $ 930 $ 5,649 $ 17,517 $ 1,394,512 $ 1,412,029 SBA loans held for sale — — — — — 13,529 13,529 Total loans $ 7,163 $ 3,775 $ 930 $ 5,649 $ 17,517 $ 1,408,041 $ 1,425,558 (1) At December 31, 2019 , nonaccrual loans included $59 thousand of loans guaranteed by the SBA. Impaired Loans The Company has defined impaired loans to be all nonperforming loans individually evaluated for impairment and TDRs. Management considers a loan impaired when, based on current information and events, it is determined that the Company will not be able to collect all amounts due according to the loan contract. Impairment is evaluated on an individual basis for SBA and commercial loans. The following table provides detail on the Company’s impaired loans that are individually evaluated for impairment with the associated allowance amount, if applicable, as of March 31, 2020 : March 31, 2020 (In thousands) Unpaid principal balance Recorded investment Specific reserves With no related allowance: SBA loans held for investment (1) $ 1,221 $ 1,062 $ — Commercial loans Commercial other 500 — — Commercial real estate 913 613 — Total commercial loans 1,413 613 — Total impaired loans with no related allowance 2,634 1,675 — With an allowance: SBA loans held for investment (1) 163 138 138 Commercial loans Commercial real estate 694 694 46 Total commercial loans 694 694 46 Total impaired loans with a related allowance 857 832 184 Total individually evaluated impaired loans: SBA loans held for investment (1) 1,384 1,200 138 Commercial loans Commercial other 500 — — Commercial real estate 1,607 1,307 46 Total commercial loans 2,107 1,307 46 Total individually evaluated impaired loans $ 3,491 $ 2,507 $ 184 (1) Balances are reduced by amount guaranteed by the SBA of $427 thousand at March 31, 2020 . The following table provides detail on the Company’s impaired loans that are individually evaluated for impairment with the associated allowance amount, if applicable, as of December 31, 2019 : December 31, 2019 (In thousands) Unpaid principal balance Recorded investment Specific reserves With no related allowance: SBA loans held for investment (1) $ 1,224 $ 1,064 $ — Commercial loans Commercial real estate 213 213 — Total commercial loans 213 213 — Total impaired loans with no related allowance 1,437 1,277 — With an allowance: SBA loans held for investment (1) 157 41 41 Commercial loans Commercial other 816 316 316 Commercial real estate 705 705 57 Total commercial loans 1,521 1,021 373 Total impaired loans with a related allowance 1,678 1,062 414 Total individually evaluated impaired loans: SBA loans held for investment (1) 1,381 1,105 41 Commercial loans Commercial other 816 316 316 Commercial real estate 918 918 57 Total commercial loans 1,734 1,234 373 Total individually evaluated impaired loans $ 3,115 $ 2,339 $ 414 (1) Balances are reduced by amount guaranteed by the SBA of $59 thousand at December 31, 2019 . Impaired loans increased $376 thousand at March 31, 2020 compared to December 31, 2019 . The increase in impaired loans was primarily due to the addition of one commercial loan totaling $913 thousand , partially offset by paydowns on two commercial loans totaling $529 thousand . The following table presents the average recorded investments in impaired loans and the related amount of interest recognized during the time period in which the loans were impaired for the three months ended March 31, 2020 and 2019 . The average balances are calculated based on the month-end balances of impaired loans. When the ultimate collectability of the total principal of an impaired loan is in doubt and the loan is on nonaccrual status, all payments are applied to principal under the cost recovery method, and therefore no interest income is recognized. The interest income recognized on impaired loans noted below represents primarily accruing TDRs and nominal amounts of income recognized on a cash basis for well-collateralized impaired loans. For the three months ended March 31, 2020 2019 (In thousands) Average recorded investment Interest income recognized on impaired loans Average recorded investment Interest income recognized on impaired loans SBA loans held for investment (1) $ 1,128 $ 3 $ 1,183 $ 4 Commercial loans SBA 504 loans 600 32 — — Commercial other 5 10 7 — Commercial real estate 1,047 12 1,789 9 Total $ 2,780 $ 57 $ 2,979 $ 13 (1) Balances are reduced by the average amount guaranteed by the SBA of $182 thousand and $100 thousand for the three months ended March 31, 2020 and 2019 , respectively. TDRs The Company's loan portfolio also includes certain loans that have been modified as TDRs. TDRs occur when a creditor, for economic or legal reasons related to a debtor’s financial condition, grants a concession to the debtor that it would not otherwise consider, unless it results in a delay in payment that is insignificant. These concessions typically include reductions in interest rate, extending the maturity of a loan, or a combination of both. When the Company modifies a loan, management evaluates for any possible impairment using either the discounted cash flows method, where the value of the modified loan is based on the present value of expected cash flows, discounted at the contractual interest rate of the original loan agreement, or by using the fair value of the collateral less selling costs if the loan is collateral-dependent. If management determines that the value of the modified loan is less than the recorded investment in the loan, impairment is recognized by segment or class of loan, as applicable, through an allowance estimate or charge-off to the allowance. This process is used, regardless of loan type, and for loans modified as TDRs that subsequently default on their modified terms. The Company had one performing TDR with a balance of $694 thousand and $705 thousand as of March 31, 2020 and December 31, 2019 , respectively, which was included in the impaired loan numbers as of such dates. At March 31, 2020 and December 31, 2019 , there were specific reserves on the performing TDR of $46 thousand and $57 thousand , respectively. The loan remains in accrual status since it continues to perform in accordance with the restructured terms. To date, the Company’s TDRs consisted of interest rate reductions, interest only periods, principal balance reductions, and maturity extensions. There were no loans modified during the three months ended March 31, 2020 and 2019 that were deemed to be TDRs. There were no loans modified as a TDR within the previous 12 months that subsequently defaulted at some point during the three months ended March 31, 2020 . In this case, the subsequent default is defined as 90 days past due or transferred to nonaccrual status.

Allowance for Loan Losses and R

Allowance for Loan Losses and Reserve for Unfunded Loan Commitments	3 Months Ended
	Mar. 31, 2020
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Allowance for Loan Losses and Reserve for Unfunded Loan Commitments	Allowance for Loan Losses and Reserve for Unfunded Loan Commitments Allowance for Loan Losses The Company has an established methodology to determine the adequacy of the allowance for loan losses that assesses the risks and losses inherent in the loan portfolio. At a minimum, the adequacy of the allowance for loan losses is reviewed by management on a quarterly basis. For purposes of determining the allowance for loan losses, the Company has segmented the loans in its portfolio by loan type. Loans are segmented into the following pools: SBA 7(a), commercial, residential mortgages, and consumer loans. Certain portfolio segments are further broken down into classes based on the associated risks within those segments and the type of collateral underlying each loan. Commercial loans are divided into the following five classes: commercial real estate, commercial real estate construction, unsecured business line of credit, commercial other, and SBA 504. Consumer loans are divided into two classes as follows: home equity and other. The standardized methodology used to assess the adequacy of the allowance includes the allocation of specific and general reserves. The same standard methodology is used, regardless of loan type. Specific reserves are made to individual impaired loans and TDRs (see Note 1 for additional information on this term). The general reserve is set based upon a representative average historical net charge-off rate adjusted for the following environmental factors: delinquency and impairment trends, charge-off and recovery trends, changes in the volume of restructured loans, volume and loan term trends, changes in risk and underwriting policy trends, staffing and experience changes, national and local economic trends, industry conditions and credit concentration changes. Within the five-year historical net charge-off rate, the Company weights the past three years more heavily as it believes it is more indicative of future charge-offs. All of the environmental factors are ranked and assigned a basis points value based on the following scale: low, low moderate, moderate, high moderate and high risk. Each environmental factor is evaluated separately for each class of loans and risk weighted based on its individual characteristics. • For SBA 7(a) and commercial loans, the estimate of loss based on pools of loans with similar characteristics is made through the use of a standardized loan grading system that is applied on an individual loan level and updated on a continuous basis. The loan grading system incorporates reviews of the financial performance of the borrower, including cash flow, debt-service coverage ratio, earnings power, debt level and equity position, in conjunction with an assessment of the borrower's industry and future prospects. It also incorporates analysis of the type of collateral and the relative loan to value ratio. • For residential mortgage and consumer loans, the estimate of loss is based on pools of loans with similar characteristics. Factors such as credit score, delinquency status and type of collateral are evaluated. Factors are updated frequently to capture the recent behavioral characteristics of the subject portfolios, as well as any changes in loss mitigation or credit origination strategies, and adjustments to the reserve factors are made as needed. According to the Company’s policy, a loss (“charge-off”) is to be recognized and charged to the allowance for loan losses as soon as a loan is recognized as uncollectable. All credits which are 90 days past due must be analyzed for the Company’s ability to collect on the credit. Once a loss is known to exist, the charge-off approval process is immediately expedited. This charge-off policy is followed for all loan types. The allocated allowance is the total of identified specific and general reserves by loan category. The allocation is not necessarily indicative of the categories in which future losses may occur. The total allowance is available to absorb losses from any segment of the portfolio. The following tables detail the activity in the allowance for loan losses by portfolio segment for the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 (In thousands) SBA held for investment Commercial Residential Consumer Total Balance, beginning of period $ 1,079 $ 9,722 $ 4,254 $ 1,340 $ 16,395 Charge-offs (25 ) (300 ) (200 ) — (525 ) Recoveries 5 1 — — 6 Net charge-offs (20 ) (299 ) (200 ) — (519 ) Provision for (credit to) loan losses charged to expense (54 ) 706 709 139 1,500 Balance, end of period $ 1,005 $ 10,129 $ 4,763 $ 1,479 $ 17,376 For the three months ended March 31, 2019 (In thousands) SBA held for investment Commercial Residential Consumer Total Balance, beginning of period $ 1,655 $ 8,705 $ 3,900 $ 1,228 $ 15,488 Charge-offs (308 ) (1 ) — (1 ) (310 ) Recoveries 1 5 — — 6 Net (charge-offs) recoveries (307 ) 4 — (1 ) (304 ) Provision for (credit to) loan losses charged to expense 330 84 116 (30 ) 500 Balance, end of period $ 1,678 $ 8,793 $ 4,016 $ 1,197 $ 15,684 The following tables present loans and their related allowance for loan losses, by portfolio segment, as of March 31, 2020 and December 31, 2019 : March 31, 2020 (In thousands) SBA held for investment Commercial Residential Consumer Total Allowance for loan losses ending balance: Individually evaluated for impairment $ 138 $ 46 $ — $ — $ 184 Collectively evaluated for impairment 867 10,083 4,763 1,479 17,192 Total $ 1,005 $ 10,129 $ 4,763 $ 1,479 $ 17,376 Loan ending balances: Individually evaluated for impairment $ 1,200 $ 1,307 $ — $ — $ 2,507 Collectively evaluated for impairment 30,497 784,770 456,072 149,695 1,421,034 Total $ 31,697 $ 786,077 $ 456,072 $ 149,695 $ 1,423,541 December 31, 2019 (In thousands) SBA held for investment Commercial Residential Consumer Total Allowance for loan losses ending balance: Individually evaluated for impairment $ 41 $ 373 $ — $ — $ 414 Collectively evaluated for impairment 1,038 9,349 4,254 1,340 15,981 Total $ 1,079 $ 9,722 $ 4,254 $ 1,340 $ 16,395 Loan ending balances: Individually evaluated for impairment $ 1,105 $ 1,234 $ — $ — $ 2,339 Collectively evaluated for impairment 34,662 763,798 467,706 143,524 1,409,690 Total $ 35,767 $ 765,032 $ 467,706 $ 143,524 $ 1,412,029 Changes in Methodology The Company did not make any changes to its allowance for loan losses methodology in the current period. Reserve for Unfunded Loan Commitments In addition to the allowance for loan losses, the Company maintains a reserve for unfunded loan commitments at a level that management believes is adequate to absorb estimated probable losses. Adjustments to the reserve are made through other expense and applied to the reserve which is classified as other liabilities. At March 31, 2020 , a $288 thousand commitment reserve was reported on the balance sheet as an “other liability”, compared to a $273 thousand commitment reserve at December 31, 2019 , due to a larger loan portfolio requiring a larger general reserve.

New Accounting Pronouncements

New Accounting Pronouncements	3 Months Ended
	Mar. 31, 2020
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments." ASU 2016-13 was issued to replace the incurred loss impairment methodology in current GAAP with an expected credit loss methodology and requires consideration of a broader range of information to determine credit loss estimates. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses. Purchased credit impaired loans will receive an allowance account at the acquisition date that represents a component of the purchase price allocation. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses, with such allowance limited to the amount by which fair value is below amortized cost. For public business entities, ASU 2016-13 is effective for interim and annual reporting periods beginning after December 15, 2019. In May 2019, FASB issued ASU 2019-05, "Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief." ASU 2019-05 was issued to address concerns with the adoption of ASU 2016-13. ASU 2019-05 gives entities the ability to irrevocable elect the fair value option in Subtopic 825-10 for certain existing financial assets upon transition to ASU 2016-03. Financial assets that are eligible for this fair value election are those that qualify under Subtopic 825-10 and are within the scope of Subtopic 326-10, "Financial Instruments - Credit Losses - Measured at Amortized Costs." An exception to this is held-to-maturity debt securities, which do not qualify for this transition election. The effective date for the amendment is the same as the effective date in ASU 2016-03. In November 2019, FASB issued ASU 2019-10, "Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates." ASU 2019-10 was issued to defer the effective dates for certain guidance in its Accounting Standard Codification ("ASC") for certain entities. The amendments in this update amend the mandatory effective dates for ASC 326, "Financial Instruments - Credit Losses", for entities eligible to be smaller reporting companies as defined by the SEC for fiscal years beginning after December 15, 2022, including interim reporting periods within that reporting period. The Company is currently evaluating the impact of the adoption of ASU 2016-13 on its consolidated financial statements. In November 2019, FASB issued ASU 2019-11, "Codification Improvements to Topic 326, Financial Instruments - Credit Losses." ASU 2019-11 was issued to address issues raise by stakeholders during the implementation of ASU 2016-13. ASU 2019-11 provides transition relief when adjusting the effective interest rate for troubled debt restructurings ("TDRs") that exist as of the adoption date, extends the disclosure relief in ASU 2019-04 to disclose accrued interest receivable balances separately from the amortized cost basis to additional disclosures involving amortized cost basis, and provides clarification regarding application of the guidance in paragraph 326-20-35-6 for financial assets secured by collateral maintenance provisions that provides a practical expedient to measure the estimate of expected credit losses by comparing the amortized cost basis of a financial asset and the fair value of collateral securing the financial asset as of the reporting date. The effective date and transition requirements for the amendment are the same as the effective date and transition requirements in ASU 2016-13. ASU 2017-04, "Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." ASU 2017-04 was issued in an effort to simplify accounting in a new standard. The amendments in this update require that an entity perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The amendment states that an entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, but the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. For public business entities, ASU 2017-04 is effective for fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performing on testing dates after January 1, 2017. The Company adopted this standard as of January 1, 2020. The adoption of this ASU did not have an impact on the Company's consolidated financial statements since the fair values of our reporting units were not lower than their respective carrying amounts at the time of our goodwill impairment analysis. ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes." ASU 2019-12 removes the exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items and removes the exception to the interim period income tax accounting when a year-to-date loss exceeds the anticipated loss for the year. ASU 2019-12 also simplifies the accounting for income taxes by requiring that an entity recognize a franchise tax that is partially based on income as an income-based tax, that an entity evaluate when a step up in the tax basis of goodwill should be considered part of the business combination in which the book goodwill originally was recognized, and that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. For public business entities, ASU 2019-12 is effective for interim and annual periods beginning after December 15, 2020. ASU 2020-01, "Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815): Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force)." ASU 2020-01 clarifies that the observable price changes in orderly transactions that should be considered when applying the measurement alternative in accordance with ASC 321 include transactions that require it to either apply or discontinue the equity method of accounting under ASC 323. ASU 2020-01 also addresses questions about how to apply the guidance in Topic 815, “Derivatives and Hedging,” for certain forward contracts and purchased options to purchase securities that, upon settlement or exercise, would be accounted for under the equity method of accounting. The ASU clarifies that, for the purpose of applying ASC 815-10-15-141(a), an entity should not consider whether, upon the settlement of the forward contract or exercise of the purchased option, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with the financial instruments guidance in Topic 825, “Financial Instruments.” For public business entities, ASU 2020-01 is effective for interim and annual periods beginning after December 15, 2020. ASU 2020-03, "Codification Improvement to Financial Instruments." ASU 2020-03 clarifies that all entities are required to provide the fair value option disclosures in paragraphs 825-10-50-24 through 50-32 of the FASB’s Accounting Standards Codification (ASC). ASU 2020-03 also clarifies that the contractual term of a net investment in a lease determined in accordance with ASC 842, “Leases,” should be the contractual term used to measure expected credit losses under ASC 326, “Financial Instruments – Credit Losses.” ASU 2020-03 also addresses amendments to ASC 860-20, “Transfers and Servicing – Sales of Financial Assets,” clarify that when an entity regains control of financial assets sold, an allowance for credit losses should be recorded in accordance with ASC 326. The effective date and transition requirements for the amendment are the same as the effective date and transition requirements in deASU 2016-13. ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." ASU 2020-04 provides temporary optional guidance intended to ease the burden of reference rate reform on financial reporting. The guidance provides optional expedients and exceptions for applying existing guidance to contract modifications, hedging relationships and other transactions that are expected to be affected by reference rate reform and meet certain scope guidance. ASU 2020-04 provides various optional expedients, including the following, for hedging relationships affected by reference rate reform, if certain criteria are met: • An entity can change certain critical terms of the hedging instrument or hedged item or transaction without having to dedesignate the relationship. • For fair value hedging relationships in which the designated interest rate is LIBOR or another rate that is expected to be discontinued, an entity may change the hedged risk to another permitted benchmark rate without dedesignating the relationship. • For cash flow hedging relationships in which the designated hedged risk is LIBOR or another rate that is expected to be discontinued, an entity may assert that the occurrence of the hedged forecasted transaction remains probable. • Certain qualifying conditions for the shortcut method and other methods that assume perfect effectiveness may be disregarded. In addition, ASU 2020-04 permits an entity to make a one-time election to sell, transfer, or both sell and transfer debt securities classified as held to maturity that reference a rate affected by reference rate reform and that were classified as held to maturity before January 1, 2020. ASU 2020-04 was effective upon its issuance on March 12, 2020. However, it cannot be applied to contract modifications that occur after December 31, 2022. With certain exceptions, the ASU also cannot be applied to hedging relationships entered into or evaluated after that date.

Derivative Financial Instrument

Derivative Financial Instruments and Hedging Activities	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments and Hedging Activities	Derivative Financial Instruments and Hedging Activities Derivative Financial Instruments The Company has derivative financial instruments in the form of interest rate swap agreements, which derive their value from underlying interest rates. These transactions involve both credit and market risk. The notional amounts are amounts on which calculations, payments, and the value of the derivatives are based. Notional amounts do not represent direct credit exposures. Direct credit exposure is limited to the net difference between the calculated amounts to be received and paid, if any. Such difference, which represents the fair value of the derivative instrument, is reflected on the Company’s balance sheet as other assets or other liabilities. The Company is exposed to credit-related losses in the event of nonperformance by the counterparties to any derivative agreement. The Company controls the credit risk of its financial contracts through credit approvals, limits and monitoring procedures, and does not expect any counterparties to fail their obligations. The Company deals only with primary dealers. Derivative instruments are generally either negotiated OTC contracts or standardized contracts executed on a recognized exchange. Negotiated OTC derivative contracts are generally entered into between two counterparties that negotiate specific agreement terms, including the underlying instrument, amount, exercise prices and maturity. Risk Management Policies – Hedging Instruments The primary focus of the Company’s asset/liability management program is to monitor the sensitivity of the Company’s net portfolio value and net income under varying interest rate scenarios to take steps to control its risks. On a quarterly basis, the Company evaluates the effectiveness of entering into any derivative agreement by measuring the cost of such an agreement in relation to the reduction in net portfolio value and net income volatility within an assumed range of interest rates. Interest Rate Risk Management – Cash Flow Hedging Instruments The Company has variable rate debt as a source of funds for use in the Company’s lending and investment activities and for other general business purposes. These debt obligations expose the Company to variability in interest payments due to changes in interest rates. If interest rates increase, interest expense increases. Conversely, if interest rates decrease, interest expense decreases. Management believes it is prudent to limit the variability of a portion of its interest payments and, therefore hedges its variable-rate interest payments. To meet this objective, management enters into interest rate swap agreements whereby the Company receives variable interest rate payments and makes fixed interest rate payments during the contract period. At March 31, 2020 , the Company had interest rate swaps with a notional amount of $100.0 million , compared to a notional amount of $60.0 million at December 31, 2019 , which were designated as cash flow hedging instruments. During the three months ended March 31, 2020, the Company entered into two new swap agreements with notional values of $20.0 million each. A summary of the Company’s outstanding interest rate swap agreements used to hedge variable rate debt at March 31, 2020 and December 31, 2019 , respectively is as follows: ໿ (In thousands, except percentages and years) March 31, 2020 December 31, 2019 Notional amount $ 100,000 $ 60,000 Fair value $ (1,173 ) $ 238 Weighted average pay rate 1.19 % 1.42 % Weighted average receive rate 1.51 % 2.19 % Weighted average maturity in years 2.58 1.25 Number of contracts 6 4 During the three months ended March 31, 2020 , the Company received variable rate London Interbank Offered Rate ("LIBOR") payments from and paid fixed rates in accordance with its interest rate swap agreements. At March 31, 2020 , the unrealized loss relating to interest rate swaps was recorded as a derivative liability, whereas at December 31, 2019 , the unrealized gain relating to interest rate swaps was recorded as a derivative asset. Changes in the fair value of the interest rate swaps designated as hedging instruments of the variability of cash flows associated with long-term debt are reported in other comprehensive income. The following table presents the net losses recorded in other comprehensive income and the consolidated financial statements relating to the cash flow derivative instruments at March 31, 2020 and 2019 , respectively: For the three months ended March 31, (In thousands) 2020 2019 Unrealized losses relating to interest rate swaps (1,410 ) (381 )

Employee Benefit Plans

Employee Benefit Plans	3 Months Ended
	Mar. 31, 2020
Employee Benefit and Share-based Payment Arrangement, Noncash Expense [Abstract]
Employee Benefit Plans	Employee Benefit Plans Stock Option Plans The Company has incentive and nonqualified option plans, which allow for the grant of options to officers, employees and members of the Board of Directors. Grants under the Company's incentive and nonqualified option plans generally vest over 3 years and must be exercised within 10 years of the date of grant. Transactions under the Company’s stock option plans for the three months ended March 31, 2020 are summarized in the following table: Shares Weighted average exercise price Weighted average remaining contractual life in years Aggregate intrinsic value Outstanding at December 31, 2019 614,311 $ 14.78 6.9 $ 4,783,402 Options granted 101,000 20.39 Options exercised (5,500 ) 6.23 Options forfeited — — Options expired — — Outstanding at March 31, 2020 709,811 $ 15.65 7.1 $ 926,893 Exercisable at March 31, 2020 436,981 $ 12.55 5.8 $ 926,893 On April 25, 2019, The Company adopted the 2019 Equity Compensation Plan providing for grants of up to 500,000 shares to be allocated between incentive and non-qualified stock options, restricted stock awards, performance units and deferred stock. The Plan replaced all previously approved and established equity plans then currently in effect. As of March 31, 2020 , 142,000 options and 30,900 shares of restricted stock have been awarded from the plan leaving 327,100 shares available for future grants. The fair values of the options granted during the three months ended March 31, 2020 and 2019 were estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: For the three months ended March 31, 2020 2019 Number of options granted 101,000 55,000 Weighted average exercise price $ 20.39 $ 20.61 Weighted average fair value of options $ 5.54 $ 6.21 Expected life in years (1) 8.66 8.23 Expected volatility (2) 27.13 % 27.08 % Risk-free interest rate (3) 1.55 % 2.55 % Dividend yield (4) 1.61 % 1.36 % (1) The expected life of the options was estimated based on historical employee behavior and represents the period of time that options granted are expected to be outstanding. (2) The expected volatility of the Company’s stock price was based on the historical volatility over the period commensurate with the expected life of the options. (3) The risk-free interest rate is the U.S. Treasury rate commensurate with the expected life of the options on the date of grant. (4) The expected dividend yield is the projected annual yield based on the grant date stock price. Upon exercise, the Company issues shares from its authorized but unissued common stock to satisfy the options. The following table presents information about options exercised during the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 2019 Number of options exercised 5,500 20,434 Total intrinsic value of options exercised $ 86,241 $ 240,403 Cash received from options exercised $ 34,265 $ 165,943 Tax deduction realized from options $ 25,264 $ 72,325 The following table summarizes information about stock options outstanding and exercisable at March 31, 2020 : Options outstanding Options exercisable Range of exercise prices Options outstanding Weighted average remaining contractual life (in years) Weighted average exercise price Options exercisable Weighted average exercise price $0.00 - $6.00 59,011 2.4 $ 5.60 59,011 $ 5.60 $6.01 - $12.00 190,767 5.0 8.73 190,767 8.73 $12.01 - $18.00 102,533 7.9 15.94 67,533 15.78 $18.01 - $24.00 357,500 8.8 20.91 119,670 20.26 Total 709,811 7.1 $ 15.65 436,981 $ 12.55 Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") Topic 718, “Compensation - Stock Compensation,” requires an entity to recognize the fair value of equity awards as compensation expense over the period during which an employee is required to provide service in exchange for such an award (vesting period). Compensation expense related to stock options and the related income tax benefit for the three months ended March 31, 2020 and 2019 are detailed in the following table: For the three months ended March 31, 2020 2019 Compensation expense $ 192,489 $ 136,356 Income tax benefit $ 55,629 $ 39,407 As of March 31, 2020 , unrecognized compensation costs related to nonvested share-based compensation arrangements granted under the Company’s stock option plans totaled approximately $1.5 million . That cost is expected to be recognized over a weighted average period of 2.2 years. Restricted Stock Awards Restricted stock is issued under the stock bonus program to reward employees and directors and to retain them by distributing stock over a period of time. Restricted stock awards granted to date vest over a period of 4 years and are recognized as compensation to the recipient over the vesting period. The awards are recorded at fair market value at the time of grant and amortized into salary expense on a straight line basis over the vesting period. The following table summarizes nonvested restricted stock activity for the three months ended March 31, 2020 : Shares Average grant date fair value Nonvested restricted stock at December 31, 2019 108,740 $ 19.18 Granted 15,000 16.63 Cancelled — — Vested (33,718 ) 17.08 Nonvested restricted stock at March 31, 2020 90,022 $ 19.54 Restricted stock awards granted during the three months ended March 31, 2020 and 2019 were as follows: For the three months ended March 31, 2020 2019 Number of shares granted 15,000 30,150 Average grant date fair value $ 16.63 $ 20.65 Compensation expense related to restricted stock for the three months ended March 31, 2020 and 2019 is detailed in the following table: For the three months ended March 31, 2020 2019 Compensation expense $ 172,905 $ 146,288 Income tax benefit $ 49,969 $ 42,277 As of March 31, 2020 , there was approximately $1.6 million of unrecognized compensation cost related to nonvested restricted stock awards granted under the Company’s stock incentive plans. That cost is expected to be recognized over a weighted average period of 2.7 years. 401(k) Savings Plan The Bank has a 401(k) savings plan covering substantially all employees. Under the Plan, an employee can contribute up to 80 percent of their salary on a tax deferred basis. The Bank may also make discretionary contributions to the Plan. The Bank contributed $185 thousand and $146 thousand to the Plan during the three months ended March 31, 2020 and 2019 , respectively. Deferred Fee Plan The Company has a deferred fee plan for Directors and executive management. Directors of the Company have the option to elect to defer up to 100 percent of their respective retainer and Board of Director fees, and each member of executive management has the option to elect to defer up to 100 percent of their year end cash bonuses. Director and executive deferred fees totaled $491 thousand and $312 thousand during the three months ended March 31, 2020 and 2019 , respectively. The interest paid on the deferred balances totaled $28 thousand and $23 thousand during the three months ended March 31, 2020 and 2019 , respectively. The fees distributed on the deferred balances totaled $2 thousand in 2020 and $3 thousand in 2019. Benefit Plans In addition to the 401(k) savings plan which covers substantially all employees, in 2015 the Company established an unfunded supplemental defined benefit plan to provide additional retirement benefits for the President and Chief Executive Officer (“CEO”) and certain key executives. On June 4, 2015, the Company approved the Supplemental Executive Retirement Plan (“SERP”) pursuant to which the President and CEO is entitled to receive certain supplemental nonqualified retirement benefits. On September 27, 2018 the Company approved a change in calculation of the Retirement Benefit payable under the SERP so that the Retirement Benefit shall be an amount equal to sixty percent ( 60% ) of the average of Executive's base salary for the thirty-six ( 36 ) months immediately preceding executive's separation from service after age 66, adjusted annually thereafter by two percent ( 2% ). The total benefit is to be made payable in fifteen annual installments. The future payments are estimated to total $6.6 million . A discount rate of four percent ( 4% ) was used to calculate the present value of the benefit obligation. The President and CEO commenced vesting in this retirement benefit on January 1, 2014, and vests an additional three percent ( 3% ) each year until fully vested on January 1, 2024. In the event that the President and CEO’s separation from service from the Company were to occur prior to full vesting, the President and CEO would be entitled to and shall be paid the vested portion of the retirement benefit calculated as of the date of separation from service. Notwithstanding the foregoing, upon a Change in Control, and provided that within 6 months following the Change in Control the President and CEO is involuntarily terminated for reasons other than “cause” or the President and CEO resigns for “good reason,” as such is defined in the SERP, or the President and CEO voluntarily terminates his employment after being offered continued employment in a position that is not a “Comparable Position,” as such is also defined in the SERP, the President and CEO shall become one hundred percent ( 100% ) vested in the full retirement benefit. No contributions or payments have been made during the three months ended March 31, 2020 . The following table summarizes the components of the net periodic pension cost of the defined benefit plan recognized during the three months ended March 31, 2020 and 2019 : For the three months ended March 31, (In thousands) 2020 2019 Service cost $ 31 $ 47 Interest cost 37 29 Amortization of prior service cost 21 21 Net periodic benefit cost $ 89 $ 97 The following table summarizes the changes in benefit obligations of the defined benefit plan during the three months ended March 31, 2020 and 2019 : For the three months ended March 31, (In thousands) 2020 2019 Benefit obligation, beginning of year $ 3,571 $ 2,747 Service cost 31 47 Interest cost 37 29 Benefit obligation, end of period $ 3,639 $ 2,823 On October 22, 2015, the Company entered into an Executive Incentive Retirement Plan (the “Plan”) with certain key executive officers other than the President and CEO. The Plan has an effective date of January 1, 2015. The Plan is an unfunded, nonqualified deferred compensation plan. For any Plan Year, a guaranteed annual Deferral Award percentage of seven and one half percent ( 7.5% ) of the participant’s annual base salary will be credited to each Participant’s Deferred Benefit Account. A discretionary annual Deferral Award equal to seven and one half percent ( 7.5% ) of the participant’s annual base salary may be credited to the Participant’s account in addition to the guaranteed Deferral Award, if the Bank exceeds the benchmarks set forth in the Annual Executive Bonus Matrix. The total Deferral Award shall never exceed fifteen percent ( 15% ) of the participant's base salary for any given Plan Year. Each Participant shall be one hundred percent ( 100% ) vested in all Deferral Awards as of the date they are awarded. As of March 31, 2020 , the Company had total year to date expenses of $24 thousand related to the Plan. The Plan is reflected on the Company’s balance sheet as accrued expenses. Certain members of management are also enrolled in a split-dollar life insurance plan with a post retirement death benefit of $250 thousand . Total expenses related to this plan were $1 thousand for the three months ended March 31, 2020 and 2019 .

Regulatory Capital

Regulatory Capital	3 Months Ended
	Mar. 31, 2020
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]
Regulatory Capital	Regulatory Capital A significant measure of the strength of a financial institution is its capital base. Federal regulators have classified and defined capital into the following components: (1) tier 1 capital, which includes tangible shareholders' equity for common stock, qualifying preferred stock and certain qualifying hybrid instruments, and (2) tier 2 capital, which includes a portion of the allowance for loan losses, subject to limitations, certain qualifying long-term debt, preferred stock and hybrid instruments, which do not qualify for tier 1 capital. The Bank is currently subject to various regulatory capital requirements administered by the FDIC. On September 17, 2019, the federal banking agencies issued a final rule providing simplified capital requirements for certain community banking organizations (banks and holding companies) with less than $10 billion in total consolidated assets, implementing provisions of The Economic Growth, Regulatory Relief, and Consumer Protection Act (“EGRRCPA”). Under the proposal, a qualifying community banking organization would be eligible to elect the community bank leverage ratio framework, or continue to measure capital under the existing Basel III requirements set forth in the New Rules. The new rule takes effect January 1, 2020, and qualifying community banking organizations may elect to opt into the new community bank leverage ratio (“CBLR”) in their call report for the first quarter of 2020. A qualifying community banking organization (“QCBO”) is defined as a bank, a savings association, a bank holding company or a savings and loan holding company with: • A leverage capital ratio of greater than 9.0%; • Total consolidated assets of less than $10.0 billion; • Total off-balance sheet exposures (excluding derivatives other than credit derivatives and unconditionally cancelable commitments) of 25% or less of total consolidated assets; and • Total trading assets and trading liabilities of 5% or less of total consolidated assets. A QCBO opting into the CBLR must maintain a CBLR of 9.0%, subject to a two quarter grace period to come back into compliance, provided that the QCBO maintains a leverage ratio of more than 8.0% during the grace period. A QCBO failing to satisfy these requirements must comply with the existing Basel III requirements as implemented by the banking regulators. The numerator of the CBLR is Tier 1 capital, as calculated under present rules. The denominator of the CBLR is the QCBO’s average assets, calculated in accordance with the QCBO’s Call Report instructions and less assets deducted from Tier 1 capital. The Bank has opted into the CBLR, and will therefore not be required to comply with the Basel III capital requirements. As of March 31, 2020, the Bank’s CBLR was 10.16%, and the Company’s CBLR was 10.56%. For comparison purposes only, we set forth below what the capital ratios for the Bank and the Company were, and would have been, under the Basel III requirements: At March 31, 2020 Required for capital adequacy purposes effective To be well-capitalized under prompt corrective action regulations Company Bank January 1, 2019 Bank Leverage ratio 10.56 % 10.16 % 4.00 % 5.00 % CET1 11.67 % 11.91 % 7.00 % (1 ) 6.50 % Tier I risk-based capital ratio 12.39 % 11.91 % 8.50 % (1 ) 8.00 % Total risk-based capital ratio 13.15 % 12.70 % 10.50 % (1 ) 10.00 % At December 31, 2019 Required for capital To be well-capitalized under prompt corrective action regulations Company Bank January 1, 2019 Bank Leverage ratio 10.59 % 10.15 % 4.000 % 5.00 % CET1 11.59 % 11.81 % 7.000 % (1 ) 6.50 % Tier I risk-based capital ratio 12.32 % 11.81 % 8.500 % (1 ) 8.00 % Total risk-based capital ratio 13.06 % 12.58 % 10.500 % (1 ) 10.00 % (1) Includes 2.5% capital conservation buffer.

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	Leases The Company follows ASU 2016-02, "Leases (Topic 842)," which revised certain aspects of recognition, measurement, presentation, and disclosure of leasing transactions. ASU 2016-02 requires that a lessee recognize the assets and liabilities on its balance sheet that arise from all leases with a term greater than 12 months. The core principle requires the lessee to recognize a liability to make lease payments and a "right-of-use" asset. Operating leases in which the Bank is the lessee are recorded as right-of-use ("ROU") assets and lease liabilities and are included in Prepaid expenses and other assets and Accrued expenses and other liabilities, respectively, on the Bank's Consolidated Balance Sheets. The Bank does not currently have any finance leases in which it is the lessee. Operating lease ROU assets represent the Bank's right to use an underlying asset during the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at lease commencement based on the present value of the remaining lease payments using a discount rate that represents our incremental borrowing rate. The incremental borrowing rate was calculated for each lease by taking a variable rate FHLB ARC product (based on Libor plus a spread) and then swapping it to a fixed rate borrowing by adding a fixed mid swap rate for the desired term. The borrowing rate for each lease is unique based on the lease term. Operating lease expense, which is comprised of amortization of the ROU asset and the implicit interest accreted on the operating lease liability, is recognized on a straight-line basis over the lease term, and is recorded in Occupancy expense in the Consolidated Statements of Income. The Bank's leases relate primarily to bank branches, office space and equipment with remaining lease terms of generally 1 to 10 years. Certain lease arrangements contain extension options which typically range from 1 to 5 years at the then fair market rental rates. As these extension options are not generally considered reasonably certain of exercise, they are not included in the lease term. Certain real estate leases have lease payments that adjust based on annual changes in the Consumer Price Index ("CPI"). The leases that are dependent upon CPI are initially measured using the index or rate at the commencement date and are included in the measurement of the lease liability. Operating lease ROU assets totaled $2.7 million at March 31, 2020 , compared to $2.8 million at December 31, 2019 . As of March 31, 2020 , operating lease liabilities totaled $2.7 million , compared to $2.8 million at December 31, 2019 . The table below summarizes our net lease cost: For the three months ended March 31, (In thousands) 2020 2019 Operating lease cost $ 148 $ 150 Net lease cost $ 148 $ 150 The table below summarizes the cash and non-cash activities associated with our leases: For the three months ended March 31, (In thousands) 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 141 $ 142 ROU assets obtained in exchange for new operating lease liabilities $ — $ 2,765 The table below summarizes other information related to our operating leases: (In thousands, except percentages and years) March 31, 2020 December 31, 2019 Weighted average remaining lease term in years 6.57 6.76 Weighted average discount rate 5.48 % 5.47 % Operating lease right-of-use assets $ 2,667 $ 2,792 The table below summarizes the maturity of remaining lease liabilities: (In thousands) March 31, 2020 2020 (excluding the three months ended March 31, 2020) $ 416 2021 528 2022 477 2023 410 2024 361 2025 and thereafter 1,036 Total lease payments $ 3,228 Less: Interest (526 ) Present value of lease liabilities $ 2,702 As of March 31, 2020 , the Corporation had not entered into any material leases that have not yet commenced.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Overview	The accompanying Consolidated Financial Statements include the accounts of Unity Bancorp, Inc. (the "Parent Company") and its wholly-owned subsidiary, Unity Bank (the "Bank" or when consolidated with the Parent Company, the "Company"), and reflect all adjustments and disclosures which are generally routine and recurring in nature, and in the opinion of management, necessary for a fair presentation of interim results. The Bank has multiple subsidiaries used to hold part of its investment and loan portfolios and OREO properties. All significant intercompany balances and transactions have been eliminated in consolidation. Certain reclassifications have been made to prior period amounts to conform to the current year presentation, with no impact on current earnings or shareholders’ equity. The financial information has been prepared in accordance with U.S. generally accepted accounting principles and has not been audited. In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and revenues and expenses during the reporting periods. Actual results could differ from those estimates. Amounts requiring the use of significant estimates include the allowance for loan losses, valuation of deferred tax and servicing assets, the carrying value of loans held for sale and other real estate owned, the valuation of securities and the determination of other-than-temporary impairment for securities and fair value disclosures. Management believes that the allowance for loan losses is adequate. While management uses available information to recognize losses on loans, future additions to the allowance for loan losses may be necessary based on changes in economic conditions. The Company has evaluated subsequent events for potential recognition and/or disclosure through the date the Consolidated Financial Statements included in this Quarterly Report on Form 10-Q were available to be issued. The markets served by the Company have been significantly impacted by COVID-19, which started during the first quarter of 2020. The Company continues to assess the financial impact of the COVID-19 pandemic. The interim unaudited Consolidated Financial Statements included herein have been prepared in accordance with instructions for Form 10-Q and the rules and regulations of the Securities and Exchange Commission (“SEC”) and consist of normal recurring adjustments necessary for the fair presentation of interim results. The results of operations for the three months ended March 31, 2020 are not necessarily indicative of the results which may be expected for the entire year. As used in this Form 10-Q, “we” and “us” and “our” refer to Unity Bancorp, Inc., and its consolidated subsidiary, Unity Bank, depending on the context. Certain information and financial disclosures required by U.S. generally accepted accounting principles have been condensed or omitted from interim reporting pursuant to SEC rules. Interim financial statements should be read in conjunction with the Company’s Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 .
Other-Than-Temporary Impairment	Other-Than-Temporary Impairment The Company has a process in place to identify securities that could potentially incur credit impairment that is other-than-temporary. This process involves monitoring late payments, pricing levels, downgrades by rating agencies, key financial ratios, financial statements, revenue forecasts and cash flow projections as indicators of credit issues. Management evaluates securities for other-than-temporary impairment at least on a quarterly basis, and more frequently when economic or market concern warrants such evaluation. This evaluation considers relevant facts and circumstances in evaluating whether a credit or interest rate-related impairment of a security is other-than-temporary. Relevant facts and circumstances considered include: (1) the extent and length of time the fair value has been below cost; (2) the reasons for the decline in value; (3) the financial position and access to capital of the issuer, including the current and future impact of any specific events and (4) for fixed maturity securities, the intent to sell a security or whether it is more likely than not the Company will be required to sell the security before the recovery of its amortized cost which, in some cases, may extend to maturity and for equity securities, our ability and intent to hold the security for a forecasted period of time that allows for the recovery in value. Management assesses its intent to sell or whether it is more likely than not that it will be required to sell a security before recovery of its amortized cost basis less any current-period credit losses. For debt securities that are considered other-than-temporarily impaired with no intent to sell and no requirement to sell prior to recovery of its amortized cost basis, the amount of the impairment is separated into the amount that is credit related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between the security’s amortized cost basis and the present value of its expected future cash flows. The remaining difference between the security’s fair value and the present value of future expected cash flows is due to factors that are not credit related and is recognized in other comprehensive income. For debt securities where management has the intent to sell, the amount of the impairment is reflected in earnings as realized losses. The present value of expected future cash flows is determined using the best estimate cash flows discounted at the effective interest rate implicit to the security at the date of purchase or the current yield to accrete an asset-backed or floating rate security. The methodology and assumptions for establishing the best estimate cash flows vary depending on the type of security. The asset-backed securities cash flow estimates are based on bond specific facts and circumstances that may include collateral characteristics, expectations of delinquency and default rates, loss severity and prepayment speeds and structural support, including subordination and guarantees. The corporate bond cash flow estimates are derived from scenario-based outcomes of expected corporate restructurings or the disposition of assets using bond specific facts and circumstances including timing, security interests and loss severity.
Transfers of Financial Assets	Transfers of Financial Assets Transfers of financial assets are accounted for as sales, when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when (1) the assets have been isolated from the Company, (2) the transferee obtains the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred assets, and (3) the Company does not maintain effective control over the transferred assets through an agreement to repurchase them before their maturity.
Loans	Loans Loans Held for Sale Loans held for sale represent the guaranteed portion of Small Business Administration (“SBA”) loans and are reflected at the lower of aggregate cost or market value. The Company originates loans to customers under an SBA program that historically has provided for SBA guarantees of up to 90 percent of each loan. The Company generally sells the guaranteed portion of its SBA loans to a third party and retains the servicing, holding the nonguaranteed portion in its portfolio. The net amount of loan origination fees on loans sold is included in the carrying value and in the gain or loss on the sale. When sales of SBA loans do occur, the premium received on the sale and the present value of future cash flows of the servicing assets are recognized in income. All criteria for sale accounting must be met in order for the loan sales to occur; see details under the “Transfers of Financial Assets” heading above. Servicing assets represent the estimated fair value of retained servicing rights, net of servicing costs, at the time loans are sold. Servicing assets are amortized in proportion to, and over the period of, estimated net servicing revenues. Impairment is evaluated based on stratifying the underlying financial assets by date of origination and term. Fair value is determined using prices for similar assets with similar characteristics, when available, or based upon discounted cash flows using market-based assumptions. Any impairment, if temporary, would be reported as a valuation allowance. Serviced loans sold to others are not included in the accompanying Consolidated Balance Sheets. Income and fees collected for loan servicing are credited to noninterest income when earned, net of amortization on the related servicing assets. Loans Held to Maturity Loans held to maturity are stated at the unpaid principal balance, net of unearned discounts and deferred loan origination fees and costs. In accordance with the level yield method, loan origination fees, net of direct loan origination costs, are deferred and recognized over the estimated life of the related loans as an adjustment to the loan yield. Interest is credited to operations primarily based upon the principal balance outstanding. Loans are reported as past due when either interest or principal is unpaid in the following circumstances: fixed payment loans when the borrower is in arrears for two or more monthly payments; open end credit for two or more billing cycles; and single payment notes if interest or principal remains unpaid for 30 days or more. Nonperforming loans consist of loans that are not accruing interest as a result of principal or interest being in default for a period of 90 days or more or when the ability to collect principal and interest according to the contractual terms is in doubt (nonaccrual loans). When a loan is classified as nonaccrual, interest accruals are discontinued and all past due interest previously recognized as income is reversed and charged against current period earnings. Generally, until the loan becomes current, any payments received from the borrower are applied to outstanding principal until such time as management determines that the financial condition of the borrower and other factors merit recognition of a portion of such payments as interest income. Loans may be returned to an accrual status when the ability to collect is reasonably assured and when the loan is brought current as to principal and interest. Loans are charged off when collection is sufficiently questionable and when the Company can no longer justify maintaining the loan as an asset on the balance sheet. Loans qualify for charge-off when, after thorough analysis, all possible sources of repayment are insufficient. These include: 1) potential future cash flows, 2) value of collateral, and/or 3) strength of co-makers and guarantors. All unsecured loans are charged off upon the establishment of the loan’s nonaccrual status. Additionally, all loans classified as a loss or that portion of the loan classified as a loss is charged off. All loan charge-offs are approved by the Board of Directors. Troubled debt restructurings ("TDRs") occur when a creditor, for economic or legal reasons related to a debtor’s financial condition, grants a concession to the debtor that it would not otherwise consider. These concessions typically include reductions in interest rate, extending the maturity of a loan, or a combination of both. Interest income on accruing TDRs is credited to operations primarily based upon the principal amount outstanding, as stated in the paragraphs above. The Company evaluates its loans for impairment. A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan agreement. The Company has defined impaired loans to be all TDRs and nonperforming loans individually evaluated for impairment. Impairment is evaluated in total for smaller-balance loans of a similar nature (consumer and residential mortgage loans), and on an individual basis for all other loans. Impairment of a loan is measured based on the present value of expected future cash flows, discounted at the loan's effective interest rate, or as a practical expedient, based on a loan’s observable market price or the fair value of collateral, net of estimated costs to sell, if the loan is collateral-dependent. If the value of the impaired loan is less than the recorded investment in the loan, the Company establishes a valuation allowance, or adjusts existing valuation allowances, with a corresponding charge to the provision for loan losses.
Allowance for Loan Losses and Reserve for Unfunded Loan Commitments	Allowance for Loan Losses and Reserve for Unfunded Loan Commitments The allowance for loan losses is maintained at a level management considers adequate to provide for probable loan losses as of the balance sheet date. The allowance is increased by provisions charged to expense and is reduced by net charge-offs. The level of the allowance is based on management’s evaluation of probable losses in the loan portfolio, after consideration of prevailing economic conditions in the Company’s market area, the volume and composition of the loan portfolio, and historical loan loss experience. The allowance for loan losses consists of specific reserves for individually impaired credits and TDRs, reserves for nonimpaired loans based on historical loss factors and reserves based on general economic factors and other qualitative risk factors such as changes in delinquency trends, industry concentrations or local/national economic trends. This risk assessment process is performed at least quarterly, and, as adjustments become necessary, they are realized in the periods in which they become known. Although management attempts to maintain the allowance at a level deemed adequate to provide for probable losses, future additions to the allowance may be necessary based upon certain factors including changes in market conditions and underlying collateral values. In addition, various regulatory agencies periodically review the adequacy of the Company’s allowance for loan losses. These agencies may require the Company to make additional provisions based on their judgments about information available to them at the time of their examination. The Company maintains an allowance for unfunded loan commitments that is maintained at a level that management believes is adequate to absorb estimated probable losses. Adjustments to the allowance are made through other expenses and applied to the allowance which is maintained in other liabilities.
Income Taxes	Income Taxes The Company accounts for income taxes according to the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using the enacted tax rates applicable to taxable income for the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation reserves are established against certain deferred tax assets when it is more likely than not that the deferred tax assets will not be realized. Increases or decreases in the valuation reserve are charged or credited to the income tax provision.When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that ultimately would be sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. The evaluation of a tax position taken is considered by itself and not offset or aggregated with other positions. Tax positions that meet the more likely than not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest and penalties associated with unrecognized tax benefits would be recognized in income tax expense on the income statement.
New Accounting Pronouncements	New Accounting Pronouncements ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments." ASU 2016-13 was issued to replace the incurred loss impairment methodology in current GAAP with an expected credit loss methodology and requires consideration of a broader range of information to determine credit loss estimates. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses. Purchased credit impaired loans will receive an allowance account at the acquisition date that represents a component of the purchase price allocation. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses, with such allowance limited to the amount by which fair value is below amortized cost. For public business entities, ASU 2016-13 is effective for interim and annual reporting periods beginning after December 15, 2019. In May 2019, FASB issued ASU 2019-05, "Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief." ASU 2019-05 was issued to address concerns with the adoption of ASU 2016-13. ASU 2019-05 gives entities the ability to irrevocable elect the fair value option in Subtopic 825-10 for certain existing financial assets upon transition to ASU 2016-03. Financial assets that are eligible for this fair value election are those that qualify under Subtopic 825-10 and are within the scope of Subtopic 326-10, "Financial Instruments - Credit Losses - Measured at Amortized Costs." An exception to this is held-to-maturity debt securities, which do not qualify for this transition election. The effective date for the amendment is the same as the effective date in ASU 2016-03. In November 2019, FASB issued ASU 2019-10, "Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates." ASU 2019-10 was issued to defer the effective dates for certain guidance in its Accounting Standard Codification ("ASC") for certain entities. The amendments in this update amend the mandatory effective dates for ASC 326, "Financial Instruments - Credit Losses", for entities eligible to be smaller reporting companies as defined by the SEC for fiscal years beginning after December 15, 2022, including interim reporting periods within that reporting period. The Company is currently evaluating the impact of the adoption of ASU 2016-13 on its consolidated financial statements. In November 2019, FASB issued ASU 2019-11, "Codification Improvements to Topic 326, Financial Instruments - Credit Losses." ASU 2019-11 was issued to address issues raise by stakeholders during the implementation of ASU 2016-13. ASU 2019-11 provides transition relief when adjusting the effective interest rate for troubled debt restructurings ("TDRs") that exist as of the adoption date, extends the disclosure relief in ASU 2019-04 to disclose accrued interest receivable balances separately from the amortized cost basis to additional disclosures involving amortized cost basis, and provides clarification regarding application of the guidance in paragraph 326-20-35-6 for financial assets secured by collateral maintenance provisions that provides a practical expedient to measure the estimate of expected credit losses by comparing the amortized cost basis of a financial asset and the fair value of collateral securing the financial asset as of the reporting date. The effective date and transition requirements for the amendment are the same as the effective date and transition requirements in ASU 2016-13. ASU 2017-04, "Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." ASU 2017-04 was issued in an effort to simplify accounting in a new standard. The amendments in this update require that an entity perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The amendment states that an entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, but the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. For public business entities, ASU 2017-04 is effective for fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performing on testing dates after January 1, 2017. The Company adopted this standard as of January 1, 2020. The adoption of this ASU did not have an impact on the Company's consolidated financial statements since the fair values of our reporting units were not lower than their respective carrying amounts at the time of our goodwill impairment analysis. ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes." ASU 2019-12 removes the exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items and removes the exception to the interim period income tax accounting when a year-to-date loss exceeds the anticipated loss for the year. ASU 2019-12 also simplifies the accounting for income taxes by requiring that an entity recognize a franchise tax that is partially based on income as an income-based tax, that an entity evaluate when a step up in the tax basis of goodwill should be considered part of the business combination in which the book goodwill originally was recognized, and that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. For public business entities, ASU 2019-12 is effective for interim and annual periods beginning after December 15, 2020. ASU 2020-01, "Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815): Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force)." ASU 2020-01 clarifies that the observable price changes in orderly transactions that should be considered when applying the measurement alternative in accordance with ASC 321 include transactions that require it to either apply or discontinue the equity method of accounting under ASC 323. ASU 2020-01 also addresses questions about how to apply the guidance in Topic 815, “Derivatives and Hedging,” for certain forward contracts and purchased options to purchase securities that, upon settlement or exercise, would be accounted for under the equity method of accounting. The ASU clarifies that, for the purpose of applying ASC 815-10-15-141(a), an entity should not consider whether, upon the settlement of the forward contract or exercise of the purchased option, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with the financial instruments guidance in Topic 825, “Financial Instruments.” For public business entities, ASU 2020-01 is effective for interim and annual periods beginning after December 15, 2020. ASU 2020-03, "Codification Improvement to Financial Instruments." ASU 2020-03 clarifies that all entities are required to provide the fair value option disclosures in paragraphs 825-10-50-24 through 50-32 of the FASB’s Accounting Standards Codification (ASC). ASU 2020-03 also clarifies that the contractual term of a net investment in a lease determined in accordance with ASC 842, “Leases,” should be the contractual term used to measure expected credit losses under ASC 326, “Financial Instruments – Credit Losses.” ASU 2020-03 also addresses amendments to ASC 860-20, “Transfers and Servicing – Sales of Financial Assets,” clarify that when an entity regains control of financial assets sold, an allowance for credit losses should be recorded in accordance with ASC 326. The effective date and transition requirements for the amendment are the same as the effective date and transition requirements in deASU 2016-13. ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." ASU 2020-04 provides temporary optional guidance intended to ease the burden of reference rate reform on financial reporting. The guidance provides optional expedients and exceptions for applying existing guidance to contract modifications, hedging relationships and other transactions that are expected to be affected by reference rate reform and meet certain scope guidance. ASU 2020-04 provides various optional expedients, including the following, for hedging relationships affected by reference rate reform, if certain criteria are met: • An entity can change certain critical terms of the hedging instrument or hedged item or transaction without having to dedesignate the relationship. • For fair value hedging relationships in which the designated interest rate is LIBOR or another rate that is expected to be discontinued, an entity may change the hedged risk to another permitted benchmark rate without dedesignating the relationship. • For cash flow hedging relationships in which the designated hedged risk is LIBOR or another rate that is expected to be discontinued, an entity may assert that the occurrence of the hedged forecasted transaction remains probable. • Certain qualifying conditions for the shortcut method and other methods that assume perfect effectiveness may be disregarded. In addition, ASU 2020-04 permits an entity to make a one-time election to sell, transfer, or both sell and transfer debt securities classified as held to maturity that reference a rate affected by reference rate reform and that were classified as held to maturity before January 1, 2020. ASU 2020-04 was effective upon its issuance on March 12, 2020. However, it cannot be applied to contract modifications that occur after December 31, 2022. With certain exceptions, the ASU also cannot be applied to hedging relationships entered into or evaluated after that date.
Benefit Plans	Benefit Plans In addition to the 401(k) savings plan which covers substantially all employees, in 2015 the Company established an unfunded supplemental defined benefit plan to provide additional retirement benefits for the President and Chief Executive Officer (“CEO”) and certain key executives. On June 4, 2015, the Company approved the Supplemental Executive Retirement Plan (“SERP”) pursuant to which the President and CEO is entitled to receive certain supplemental nonqualified retirement benefits. On September 27, 2018 the Company approved a change in calculation of the Retirement Benefit payable under the SERP so that the Retirement Benefit shall be an amount equal to sixty percent ( 60% ) of the average of Executive's base salary for the thirty-six ( 36 ) months immediately preceding executive's separation from service after age 66, adjusted annually thereafter by two percent ( 2% ). The total benefit is to be made payable in fifteen annual installments. The future payments are estimated to total $6.6 million . A discount rate of four percent ( 4% ) was used to calculate the present value of the benefit obligation. The President and CEO commenced vesting in this retirement benefit on January 1, 2014, and vests an additional three percent ( 3% ) each year until fully vested on January 1, 2024. In the event that the President and CEO’s separation from service from the Company were to occur prior to full vesting, the President and CEO would be entitled to and shall be paid the vested portion of the retirement benefit calculated as of the date of separation from service. Notwithstanding the foregoing, upon a Change in Control, and provided that within 6 months following the Change in Control the President and CEO is involuntarily terminated for reasons other than “cause” or the President and CEO resigns for “good reason,” as such is defined in the SERP, or the President and CEO voluntarily terminates his employment after being offered continued employment in a position that is not a “Comparable Position,” as such is also defined in the SERP, the President and CEO shall become one hundred percent ( 100% ) vested in the full retirement benefit.
Leases	Leases The Company follows ASU 2016-02, "Leases (Topic 842)," which revised certain aspects of recognition, measurement, presentation, and disclosure of leasing transactions. ASU 2016-02 requires that a lessee recognize the assets and liabilities on its balance sheet that arise from all leases with a term greater than 12 months. The core principle requires the lessee to recognize a liability to make lease payments and a "right-of-use" asset. Operating leases in which the Bank is the lessee are recorded as right-of-use ("ROU") assets and lease liabilities and are included in Prepaid expenses and other assets and Accrued expenses and other liabilities, respectively, on the Bank's Consolidated Balance Sheets. The Bank does not currently have any finance leases in which it is the lessee. Operating lease ROU assets represent the Bank's right to use an underlying asset during the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at lease commencement based on the present value of the remaining lease payments using a discount rate that represents our incremental borrowing rate. The incremental borrowing rate was calculated for each lease by taking a variable rate FHLB ARC product (based on Libor plus a spread) and then swapping it to a fixed rate borrowing by adding a fixed mid swap rate for the desired term. The borrowing rate for each lease is unique based on the lease term. Operating lease expense, which is comprised of amortization of the ROU asset and the implicit interest accreted on the operating lease liability, is recognized on a straight-line basis over the lease term, and is recorded in Occupancy expense in the Consolidated Statements of Income. The Bank's leases relate primarily to bank branches, office space and equipment with remaining lease terms of generally 1 to 10 years. Certain lease arrangements contain extension options which typically range from 1 to 5 years at the then fair market rental rates. As these extension options are not generally considered reasonably certain of exercise, they are not included in the lease term. Certain real estate leases have lease payments that adjust based on annual changes in the Consumer Price Index ("CPI"). The leases that are dependent upon CPI are initially measured using the index or rate at the commencement date and are included in the measurement of the lease liability.

Net Income per Share (Tables)

Net Income per Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Reconciliation of Calculation of Basic and Diluted Income Per Share	The following is a reconciliation of the calculation of basic and diluted income per share: For the three months ended March 31, (In thousands, except per share amounts) 2020 2019 Net income $ 5,368 $ 5,740 Weighted average common shares outstanding - Basic 10,883 10,801 Plus: Potential dilutive common stock equivalents 154 154 Weighted average common shares outstanding - Diluted 11,037 10,955 Net income per common share - Basic $ 0.49 $ 0.53 Net income per common share - Diluted 0.49 0.52 Stock options and common stock excluded from the income per share calculation as their effect would have been anti-dilutive 363 209

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Mar. 31, 2020
Stockholders' Equity Note [Abstract]
Changes In Other Comprehensive (Loss) Income	The following tables show the changes in other comprehensive income (loss) for the three months ended March 31, 2020 and 2019 , net of tax: For the three months ended March 31, 2020 (In thousands) Net unrealized gains (losses) on securities Adjustments related to defined benefit plan Net unrealized gains (losses) from cash flow hedges Accumulated other comprehensive income (loss) Balance, beginning of period (1) $ 316 $ (295 ) $ 168 $ 189 Other comprehensive loss before reclassifications (131 ) — (1,004 ) (1,135 ) Less amounts reclassified from accumulated other comprehensive loss (134 ) (15 ) — (149 ) Period change 3 15 (1,004 ) (986 ) Balance, end of period (1) $ 319 $ (280 ) $ (836 ) $ (797 ) For the three months ended March 31, 2019 (In thousands) Net unrealized (losses) gains on securities Adjustments related to defined benefit plan Net unrealized gains (losses) from cash flow hedges Accumulated other comprehensive loss Balance, beginning of period (1) $ (721 ) $ (431 ) $ 1,030 $ (122 ) Other comprehensive income (loss) before reclassifications 240 — (302 ) (62 ) Less amounts reclassified from accumulated other comprehensive income (loss) 79 (91 ) — (12 ) Period change 161 91 (302 ) (50 ) Balance, end of period (1) $ (560 ) $ (340 ) $ 728 $ (172 )

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Balances of Assets And Liabilities Measured at Fair Value on Recurring Basis	The tables below present the balances of assets and liabilities measured at fair value on a recurring basis as of March 31, 2020 and December 31, 2019 : Fair Value Measurements at March 31, 2020 Using (In thousands) Assets/Liabilities Measured at Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Measured on a recurring basis: Assets: Debt securities available for sale: U.S. Government sponsored entities $ 5,781 $ — $ 5,781 $ — State and political subdivisions 3,439 — 3,439 — Residential mortgage-backed securities 23,850 — 23,850 — Corporate and other securities 23,220 — 23,220 — Total debt securities available for sale $ 56,290 $ — $ 56,290 $ — Equity securities with readily determinable fair values 1,712 — 1,712 — Total equity securities $ 1,712 $ — $ 1,712 $ — Loans held for sale 11,658 — 11,658 — Total loans held for sale $ 11,658 — $ 11,658 — Interest rate swap agreements (1,173 ) — (1,173 ) — Total swap agreements $ (1,173 ) $ — $ (1,173 ) $ — Fair value Measurements at December 31, 2019 Using (In thousands) Assets/Liabilities Measured at Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Measured on a recurring basis: Assets: Debt securities available for sale: U.S. Government sponsored entities $ 5,753 $ — $ 5,753 $ — State and political subdivisions 5,154 — 5,154 — Residential mortgage-backed securities 27,964 — 27,964 — Corporate and other securities 25,404 — 25,404 — Total debt securities available for sale $ 64,275 $ — $ 64,275 $ — Equity securities with readily determinable fair values 2,289 — 2,289 — Total equity securities $ 2,289 $ — $ 2,289 $ — Loans held for sale 14,862 14,862 Total loans held for sale $ 14,862 $ 14,862 Interest rate swap agreements 238 — 238 — Total swap agreements $ 238 $ — $ 238 $ —
Assets and Liabilities Subject to Fair Value Adjustments (Impairment) on Non-Recurring Basis Carried on Balance Sheet by Caption and by Level within Hierarchy	The following tables present the assets and liabilities subject to fair value adjustments (impairment) on a non-recurring basis carried on the balance sheet by caption and by level within the hierarchy (as described above): Fair Value Measurements at March 31, 2020 Using (In thousands) Assets/Liabilities Measured at Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Net Credit During Period Measured on a non-recurring basis: Financial assets: OREO $ 1,523 $ — $ — $ 1,523 $ (200 ) Impaired collateral-dependent loans 2,323 — — 2,323 (230 ) Fair Value Measurements at December 31, 2019 Using (In thousands) Assets/Liabilities Measured at Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Net Credit During Period Financial assets: OREO $ 1,723 $ — $ — $ 1,723 $ (231 ) Impaired collateral-dependent loans 1,925 — — 1,925 (253 )
Carrying Amount and Estimated Fair Values of Financial Instruments	The table below presents the carrying amount and estimated fair values of the Company’s financial instruments presented as of March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 (In thousands) Fair value level Carrying amount Estimated fair value Carrying amount Estimated fair value Financial assets: Cash and cash equivalents Level 1 $ 178,995 $ 178,995 $ 158,016 $ 158,016 Securities Level 2 58,002 58,002 66,564 66,564 SBA loans held for sale Level 2 10,726 11,658 13,529 14,862 Loans, net of allowance for loan losses (1) Level 2 1,411,543 1,427,787 1,395,634 1,398,997 FHLB stock Level 2 9,054 9,054 14,184 14,184 Servicing assets Level 3 2,138 2,138 2,026 2,026 Accrued interest receivable Level 2 7,396 7,396 6,984 6,984 OREO Level 3 1,523 1,523 1,723 1,723 Financial liabilities: Deposits Level 2 1,378,618 1,385,200 1,250,114 1,252,082 Borrowed funds and subordinated debentures Level 2 179,310 180,911 293,310 292,766 Accrued interest payable Level 2 237 237 455 455 (1) Includes collateral-dependent impaired loans that are considered Level 3 and reported separately in the tables under the “Fair Value on a Nonrecurring Basis” heading. Collateral-dependent impaired loans, net of specific reserves totaled $2.3 million and $1.9 million at March 31, 2020 and December 31, 2019 , respectively.

Securities (Tables)

Securities (Tables)	3 Months Ended
	Mar. 31, 2020
Marketable Securities [Abstract]
Reconciliation from Amortized Cost to Estimated Fair Value of Marketable Securities	This table provides the major components of debt securities available for sale ("AFS") and equity securities with readily determinable fair values ("equity securities") at amortized cost and estimated fair value at March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 (In thousands) Amortized cost Gross unrealized gains Gross unrealized losses Estimated fair value Amortized cost Gross unrealized gains Gross unrealized losses Estimated fair value Available for sale: U.S. Government sponsored entities $ 5,749 $ 32 $ — $ 5,781 $ 5,751 $ 4 $ (2 ) $ 5,753 State and political subdivisions 3,581 7 (149 ) 3,439 4,992 174 (12 ) 5,154 Residential mortgage-backed securities 23,293 639 (82 ) 23,850 27,698 372 (106 ) 27,964 Corporate and other securities 23,271 235 (286 ) 23,220 25,442 230 (268 ) 25,404 Total debt securities available for sale $ 55,894 $ 913 $ (517 ) $ 56,290 $ 63,883 $ 780 $ (388 ) $ 64,275 Equity securities: Total equity securities $ 2,112 $ — $ (400 ) $ 1,712 $ 2,218 $ 142 $ (71 ) $ 2,289
Schedule of Marketable Securities by Contractual Maturity	This table provides the remaining contractual maturities and yields of securities within the investment portfolios. The carrying value of securities at March 31, 2020 is distributed by contractual maturity. Mortgage-backed securities and other securities, which may have principal prepayment provisions, are distributed based on contractual maturity. Expected maturities will differ materially from contractual maturities as a result of early prepayments and calls. Within one year After one through five years After five through ten years After ten years Total carrying value (In thousands, except percentages) Amount Yield Amount Yield Amount Yield Amount Yield Amount Yield Available for sale at fair value: U.S. Government sponsored entities $ 3,776 1.61 % $ 2,005 2.16 % $ — — % $ — — % $ 5,781 1.80 % State and political subdivisions 195 3.80 600 3.92 1,748 3.16 896 2.74 3,439 3.22 Residential mortgage-backed securities 2 4.76 322 2.35 2,331 2.48 21,195 2.80 23,850 2.76 Corporate and other securities — — 1,610 3.49 16,371 4.77 5,239 4.87 23,220 4.70 Total debt securities available for sale $ 3,973 1.72 % $ 4,537 2.88 % $ 20,450 4.37 % $ 27,330 3.19 % $ 56,290 3.49 % Equity Securities at fair value: Total equity securities $ — — % $ — — % $ — — % $ 1,712 2.72 % $ 1,712 2.72 %
Schedule of Marketable Securities in Unrealized Loss Position	The fair value of securities with unrealized losses by length of time that the individual securities have been in a continuous unrealized loss position at March 31, 2020 and December 31, 2019 are as follows: March 31, 2020 Less than 12 months 12 months and greater Total (In thousands, except number in a loss position) Total number in a loss position Estimated fair value Unrealized loss Estimated fair value Unrealized loss Estimated fair value Unrealized loss Available for sale: State and political subdivisions 3 $ 1,246 $ (109 ) $ 896 $ (40 ) $ 2,142 $ (149 ) Residential mortgage-backed securities 7 2,526 (12 ) 3,042 (70 ) 5,568 (82 ) Corporate and other securities 6 3,311 (55 ) 3,758 (231 ) 7,069 (286 ) Total temporarily impaired securities 16 $ 7,083 $ (176 ) $ 7,696 $ (341 ) $ 14,779 $ (517 ) December 31, 2019 Less than 12 months 12 months and greater Total (In thousands, except number in a loss position) Total number in a loss position Estimated fair value Unrealized loss Estimated fair value Unrealized loss Estimated fair value Unrealized loss Available for sale: U.S. Government sponsored entities 1 $ — $ — $ 1,995 $ (2 ) $ 1,995 $ (2 ) State and political subdivisions 1 — — 1,013 (12 ) 1,013 (12 ) Residential mortgage-backed securities 10 3,707 (27 ) 4,996 (79 ) 8,703 (106 ) Corporate and other securities 6 3,366 (13 ) 3,735 (255 ) 7,101 (268 ) Total temporarily impaired securities 18 $ 7,073 $ (40 ) $ 11,739 $ (348 ) $ 18,812 $ (388 )
Schedule of Realized Gain (Loss)	Gross realized gains and losses on securities for the three months ended March 31, 2020 and 2019 are detailed in the table below: For the three months ended March 31, (In thousands) 2020 2019 Available for sale: Realized gains $ 296 $ — Realized losses — — Total debt securities available for sale 296 — Net gains on sales of securities $ 296 $ —
Equity Securities, Gains and Losses	The following is a summary of unrealized and realized gains and losses recognized in net income on equity securities during the three months ended March 31, 2020 and 2019: For the three months ended March 31, (In thousands) 2020 2019 Net (losses) gains recognized during the period on equity securities $ (471 ) $ 100 Net gains recognized during the period on equity securities sold during the period 5 — Unrealized (losses) gains recognized during the reporting period on equity securities still held at the reporting date $ (466 ) $ 100

Loans (Tables)

Loans (Tables)	3 Months Ended
	Mar. 31, 2020
Loans and Leases Receivable Disclosure [Abstract]
Classification of Loans By Class	The following table sets forth the classification of loans by class, including unearned fees, deferred costs and excluding the allowance for loan losses as of March 31, 2020 and December 31, 2019 : (In thousands) March 31, 2020 December 31, 2019 SBA loans held for investment $ 37,074 $ 35,767 Commercial loans SBA 504 loans 25,185 26,726 Commercial other 120,029 112,014 Commercial real estate 586,336 578,643 Commercial real estate construction 54,528 47,649 Residential mortgage loans 456,072 467,706 Consumer loans Home equity 75,240 69,589 Consumer other 74,455 73,935 Total loans held for investment $ 1,428,919 $ 1,412,029 SBA loans held for sale 10,726 13,529 Total loans $ 1,439,645 $ 1,425,558
Loan Portfolio by Class According to Credit Quality Indicators	The tables below detail the Company’s loan portfolio by class according to their credit quality indicators discussed in the paragraphs above as of March 31, 2020 : March 31, 2020 SBA, SBA 504 & Commercial loans - Internal risk ratings (In thousands) Pass Special mention Substandard Total SBA loans held for investment $ 35,994 $ — $ 1,080 $ 37,074 Commercial loans SBA 504 loans 23,374 1,779 32 25,185 Commercial other 114,840 3,525 1,664 120,029 Commercial real estate 584,044 749 1,543 586,336 Commercial real estate construction 54,528 — — 54,528 Total commercial loans 776,786 6,053 3,239 786,078 Total SBA, SBA 504 and commercial loans $ 812,780 $ 6,053 $ 4,319 $ 823,152 Residential mortgage & Consumer loans - Performing/Nonperforming (In thousands) Performing Nonperforming Total Residential mortgage loans $ 449,162 $ 6,910 $ 456,072 Consumer loans Home equity 74,735 505 75,240 Consumer other 74,455 — 74,455 Total consumer loans 149,190 505 149,695 Total residential mortgage and consumer loans $ 598,352 $ 7,415 $ 605,767 The tables below detail the Company’s loan portfolio by class according to their credit quality indicators discussed in the paragraphs above as of December 31, 2019 : December 31, 2019 SBA, SBA 504 & Commercial loans - Internal risk ratings (In thousands) Pass Special mention Substandard Total SBA loans held for investment $ 34,202 $ 1,115 $ 450 $ 35,767 Commercial loans SBA 504 loans 24,878 1,808 40 26,726 Commercial other 107,220 3,361 1,433 112,014 Commercial real estate 576,326 758 1,559 578,643 Commercial real estate construction 47,649 — — 47,649 Total commercial loans 756,073 5,927 3,032 765,032 Total SBA, SBA 504 and commercial loans $ 790,275 $ 7,042 $ 3,482 $ 800,799 Residential mortgage & Consumer loans - Performing/Nonperforming (In thousands) Performing Nonperforming Total Residential mortgage loans $ 463,770 $ 3,936 $ 467,706 Consumer loans Home equity 69,589 — 69,589 Consumer other 73,915 20 73,935 Total consumer loans 143,504 20 143,524 Total residential mortgage and consumer loans $ 607,274 $ 3,956 $ 611,230
Aging Analysis of Past Due and Nonaccrual Loans by Loan Class	The following tables set forth an aging analysis of past due and nonaccrual loans as of March 31, 2020 and December 31, 2019 : March 31, 2020 (In thousands) 30-59 days past due 60-89 days past due 90+ days and still accruing Nonaccrual (1) Total past due Current Total loans SBA loans held for investment $ 131 $ 154 $ — $ 1,627 $ 1,912 $ 35,162 $ 37,074 Commercial loans SBA 504 loans — — — — — 25,185 25,185 Commercial other 566 71 — — 637 119,392 120,029 Commercial real estate 785 75 — 613 1,473 584,863 586,336 Commercial real estate construction — — — — — 54,528 54,528 Residential mortgage loans 5,880 373 — 6,910 13,163 442,909 456,072 Consumer loans Home equity 561 329 — 505 1,395 73,845 75,240 Consumer other — — — — — 74,455 74,455 Total loans held for investment $ 7,923 $ 1,002 $ — $ 9,655 $ 18,580 $ 1,410,339 $ 1,428,919 SBA loans held for sale — — — — — 10,726 10,726 Total loans $ 7,923 $ 1,002 $ — $ 9,655 $ 18,580 $ 1,421,065 $ 1,439,645 (1) At March 31, 2020 , nonaccrual loans included $427 thousand of loans guaranteed by the SBA. December 31, 2019 (In thousands) 30-59 days past due 60-89 days past due 90+ days and still accruing Nonaccrual (1) Total past due Current Total loans SBA loans held for investment $ 1,048 $ — $ — $ 1,164 $ 2,212 $ 33,555 $ 35,767 Commercial loans SBA 504 loans — 1,808 — — 1,808 24,918 26,726 Commercial other 71 — — 316 387 111,627 112,014 Commercial real estate 215 — — 213 428 578,215 578,643 Commercial real estate construction — — — — — 47,649 47,649 Residential mortgage loans 4,383 1,676 930 3,936 10,925 456,781 467,706 Consumer loans Home equity 1,446 178 — — 1,624 67,965 69,589 Consumer other — 113 — 20 133 73,802 73,935 Total loans held for investment $ 7,163 $ 3,775 $ 930 $ 5,649 $ 17,517 $ 1,394,512 $ 1,412,029 SBA loans held for sale — — — — — 13,529 13,529 Total loans $ 7,163 $ 3,775 $ 930 $ 5,649 $ 17,517 $ 1,408,041 $ 1,425,558 (1) At December 31, 2019 , nonaccrual loans included $59 thousand of loans guaranteed by the SBA.
Impaired Loans with Associated Allowance Amount	The following table provides detail on the Company’s impaired loans that are individually evaluated for impairment with the associated allowance amount, if applicable, as of March 31, 2020 : March 31, 2020 (In thousands) Unpaid principal balance Recorded investment Specific reserves With no related allowance: SBA loans held for investment (1) $ 1,221 $ 1,062 $ — Commercial loans Commercial other 500 — — Commercial real estate 913 613 — Total commercial loans 1,413 613 — Total impaired loans with no related allowance 2,634 1,675 — With an allowance: SBA loans held for investment (1) 163 138 138 Commercial loans Commercial real estate 694 694 46 Total commercial loans 694 694 46 Total impaired loans with a related allowance 857 832 184 Total individually evaluated impaired loans: SBA loans held for investment (1) 1,384 1,200 138 Commercial loans Commercial other 500 — — Commercial real estate 1,607 1,307 46 Total commercial loans 2,107 1,307 46 Total individually evaluated impaired loans $ 3,491 $ 2,507 $ 184 (1) Balances are reduced by amount guaranteed by the SBA of $427 thousand at March 31, 2020 . The following table provides detail on the Company’s impaired loans that are individually evaluated for impairment with the associated allowance amount, if applicable, as of December 31, 2019 : December 31, 2019 (In thousands) Unpaid principal balance Recorded investment Specific reserves With no related allowance: SBA loans held for investment (1) $ 1,224 $ 1,064 $ — Commercial loans Commercial real estate 213 213 — Total commercial loans 213 213 — Total impaired loans with no related allowance 1,437 1,277 — With an allowance: SBA loans held for investment (1) 157 41 41 Commercial loans Commercial other 816 316 316 Commercial real estate 705 705 57 Total commercial loans 1,521 1,021 373 Total impaired loans with a related allowance 1,678 1,062 414 Total individually evaluated impaired loans: SBA loans held for investment (1) 1,381 1,105 41 Commercial loans Commercial other 816 316 316 Commercial real estate 918 918 57 Total commercial loans 1,734 1,234 373 Total individually evaluated impaired loans $ 3,115 $ 2,339 $ 414 (1) Balances are reduced by amount guaranteed by the SBA of $59 thousand at December 31, 2019 .
Average Recorded Investments in Impaired Loans and Related Amount of Interest Recognized	The following table presents the average recorded investments in impaired loans and the related amount of interest recognized during the time period in which the loans were impaired for the three months ended March 31, 2020 and 2019 . The average balances are calculated based on the month-end balances of impaired loans. When the ultimate collectability of the total principal of an impaired loan is in doubt and the loan is on nonaccrual status, all payments are applied to principal under the cost recovery method, and therefore no interest income is recognized. The interest income recognized on impaired loans noted below represents primarily accruing TDRs and nominal amounts of income recognized on a cash basis for well-collateralized impaired loans. For the three months ended March 31, 2020 2019 (In thousands) Average recorded investment Interest income recognized on impaired loans Average recorded investment Interest income recognized on impaired loans SBA loans held for investment (1) $ 1,128 $ 3 $ 1,183 $ 4 Commercial loans SBA 504 loans 600 32 — — Commercial other 5 10 7 — Commercial real estate 1,047 12 1,789 9 Total $ 2,780 $ 57 $ 2,979 $ 13 (1) Balances are reduced by the average amount guaranteed by the SBA of $182 thousand and $100 thousand for the three months ended March 31, 2020 and 2019 , respectively.

Allowance for Loan Losses and_2

Allowance for Loan Losses and Reserve for Unfunded Loan Commitments (Tables)	3 Months Ended
	Mar. 31, 2020
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Activity in Allowance for Loan Losses by Portfolio Segment	The following tables detail the activity in the allowance for loan losses by portfolio segment for the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 (In thousands) SBA held for investment Commercial Residential Consumer Total Balance, beginning of period $ 1,079 $ 9,722 $ 4,254 $ 1,340 $ 16,395 Charge-offs (25 ) (300 ) (200 ) — (525 ) Recoveries 5 1 — — 6 Net charge-offs (20 ) (299 ) (200 ) — (519 ) Provision for (credit to) loan losses charged to expense (54 ) 706 709 139 1,500 Balance, end of period $ 1,005 $ 10,129 $ 4,763 $ 1,479 $ 17,376 For the three months ended March 31, 2019 (In thousands) SBA held for investment Commercial Residential Consumer Total Balance, beginning of period $ 1,655 $ 8,705 $ 3,900 $ 1,228 $ 15,488 Charge-offs (308 ) (1 ) — (1 ) (310 ) Recoveries 1 5 — — 6 Net (charge-offs) recoveries (307 ) 4 — (1 ) (304 ) Provision for (credit to) loan losses charged to expense 330 84 116 (30 ) 500 Balance, end of period $ 1,678 $ 8,793 $ 4,016 $ 1,197 $ 15,684
Allowance for Credit Losses on Financing Receivables on Basis of Impairment Method	The following tables present loans and their related allowance for loan losses, by portfolio segment, as of March 31, 2020 and December 31, 2019 : March 31, 2020 (In thousands) SBA held for investment Commercial Residential Consumer Total Allowance for loan losses ending balance: Individually evaluated for impairment $ 138 $ 46 $ — $ — $ 184 Collectively evaluated for impairment 867 10,083 4,763 1,479 17,192 Total $ 1,005 $ 10,129 $ 4,763 $ 1,479 $ 17,376 Loan ending balances: Individually evaluated for impairment $ 1,200 $ 1,307 $ — $ — $ 2,507 Collectively evaluated for impairment 30,497 784,770 456,072 149,695 1,421,034 Total $ 31,697 $ 786,077 $ 456,072 $ 149,695 $ 1,423,541 December 31, 2019 (In thousands) SBA held for investment Commercial Residential Consumer Total Allowance for loan losses ending balance: Individually evaluated for impairment $ 41 $ 373 $ — $ — $ 414 Collectively evaluated for impairment 1,038 9,349 4,254 1,340 15,981 Total $ 1,079 $ 9,722 $ 4,254 $ 1,340 $ 16,395 Loan ending balances: Individually evaluated for impairment $ 1,105 $ 1,234 $ — $ — $ 2,339 Collectively evaluated for impairment 34,662 763,798 467,706 143,524 1,409,690 Total $ 35,767 $ 765,032 $ 467,706 $ 143,524 $ 1,412,029

Derivative Financial Instrume_2

Derivative Financial Instruments and Hedging Activities (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Interest Rate Derivatives	໿ (In thousands, except percentages and years) March 31, 2020 December 31, 2019 Notional amount $ 100,000 $ 60,000 Fair value $ (1,173 ) $ 238 Weighted average pay rate 1.19 % 1.42 % Weighted average receive rate 1.51 % 2.19 % Weighted average maturity in years 2.58 1.25 Number of contracts 6 4
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)	The following table presents the net losses recorded in other comprehensive income and the consolidated financial statements relating to the cash flow derivative instruments at March 31, 2020 and 2019 , respectively: For the three months ended March 31, (In thousands) 2020 2019 Unrealized losses relating to interest rate swaps (1,410 ) (381 )

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	3 Months Ended
	Mar. 31, 2020
Employee Benefit and Share-based Payment Arrangement, Noncash Expense [Abstract]
Transactions Under the Company’s Stock Option Plans	Transactions under the Company’s stock option plans for the three months ended March 31, 2020 are summarized in the following table: Shares Weighted average exercise price Weighted average remaining contractual life in years Aggregate intrinsic value Outstanding at December 31, 2019 614,311 $ 14.78 6.9 $ 4,783,402 Options granted 101,000 20.39 Options exercised (5,500 ) 6.23 Options forfeited — — Options expired — — Outstanding at March 31, 2020 709,811 $ 15.65 7.1 $ 926,893 Exercisable at March 31, 2020 436,981 $ 12.55 5.8 $ 926,893
Stock Options, Valuation Assumptions	The fair values of the options granted during the three months ended March 31, 2020 and 2019 were estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: For the three months ended March 31, 2020 2019 Number of options granted 101,000 55,000 Weighted average exercise price $ 20.39 $ 20.61 Weighted average fair value of options $ 5.54 $ 6.21 Expected life in years (1) 8.66 8.23 Expected volatility (2) 27.13 % 27.08 % Risk-free interest rate (3) 1.55 % 2.55 % Dividend yield (4) 1.61 % 1.36 % (1) The expected life of the options was estimated based on historical employee behavior and represents the period of time that options granted are expected to be outstanding. (2) The expected volatility of the Company’s stock price was based on the historical volatility over the period commensurate with the expected life of the options. (3) The risk-free interest rate is the U.S. Treasury rate commensurate with the expected life of the options on the date of grant. (4) The expected dividend yield is the projected annual yield based on the grant date stock price.
Schedule of Cash Proceeds Received from Share-based Payment Awards	Upon exercise, the Company issues shares from its authorized but unissued common stock to satisfy the options. The following table presents information about options exercised during the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 2019 Number of options exercised 5,500 20,434 Total intrinsic value of options exercised $ 86,241 $ 240,403 Cash received from options exercised $ 34,265 $ 165,943 Tax deduction realized from options $ 25,264 $ 72,325
Schedule of Stock Options, by Exercise Price Range	The following table summarizes information about stock options outstanding and exercisable at March 31, 2020 : Options outstanding Options exercisable Range of exercise prices Options outstanding Weighted average remaining contractual life (in years) Weighted average exercise price Options exercisable Weighted average exercise price $0.00 - $6.00 59,011 2.4 $ 5.60 59,011 $ 5.60 $6.01 - $12.00 190,767 5.0 8.73 190,767 8.73 $12.01 - $18.00 102,533 7.9 15.94 67,533 15.78 $18.01 - $24.00 357,500 8.8 20.91 119,670 20.26 Total 709,811 7.1 $ 15.65 436,981 $ 12.55
Allocation of Share-based Compensation Costs	Compensation expense related to stock options and the related income tax benefit for the three months ended March 31, 2020 and 2019 are detailed in the following table: For the three months ended March 31, 2020 2019 Compensation expense $ 192,489 $ 136,356 Income tax benefit $ 55,629 $ 39,407 Compensation expense related to restricted stock for the three months ended March 31, 2020 and 2019 is detailed in the following table: For the three months ended March 31, 2020 2019 Compensation expense $ 172,905 $ 146,288 Income tax benefit $ 49,969 $ 42,277
Summary of Nonvested Restricted Stock Activity	The following table summarizes nonvested restricted stock activity for the three months ended March 31, 2020 : Shares Average grant date fair value Nonvested restricted stock at December 31, 2019 108,740 $ 19.18 Granted 15,000 16.63 Cancelled — — Vested (33,718 ) 17.08 Nonvested restricted stock at March 31, 2020 90,022 $ 19.54
Restricted Stock Grants	Restricted stock awards granted during the three months ended March 31, 2020 and 2019 were as follows: For the three months ended March 31, 2020 2019 Number of shares granted 15,000 30,150 Average grant date fair value $ 16.63 $ 20.65
Summary of Components of Net Periodic Pension Cost of Defined Benefit Plan Recognized	The following table summarizes the components of the net periodic pension cost of the defined benefit plan recognized during the three months ended March 31, 2020 and 2019 : For the three months ended March 31, (In thousands) 2020 2019 Service cost $ 31 $ 47 Interest cost 37 29 Amortization of prior service cost 21 21 Net periodic benefit cost $ 89 $ 97
Summary Of Changes In Benefit Obligations Of Defined Benefit Plan	The following table summarizes the changes in benefit obligations of the defined benefit plan during the three months ended March 31, 2020 and 2019 : For the three months ended March 31, (In thousands) 2020 2019 Benefit obligation, beginning of year $ 3,571 $ 2,747 Service cost 31 47 Interest cost 37 29 Benefit obligation, end of period $ 3,639 $ 2,823

Regulatory Capital (Tables)

Regulatory Capital (Tables)	3 Months Ended
	Mar. 31, 2020
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]
Schedule of Compliance with Regulatory Capital Requirements under Banking Regulations	At March 31, 2020 Required for capital adequacy purposes effective To be well-capitalized under prompt corrective action regulations Company Bank January 1, 2019 Bank Leverage ratio 10.56 % 10.16 % 4.00 % 5.00 % CET1 11.67 % 11.91 % 7.00 % (1 ) 6.50 % Tier I risk-based capital ratio 12.39 % 11.91 % 8.50 % (1 ) 8.00 % Total risk-based capital ratio 13.15 % 12.70 % 10.50 % (1 ) 10.00 % At December 31, 2019 Required for capital To be well-capitalized under prompt corrective action regulations Company Bank January 1, 2019 Bank Leverage ratio 10.59 % 10.15 % 4.000 % 5.00 % CET1 11.59 % 11.81 % 7.000 % (1 ) 6.50 % Tier I risk-based capital ratio 12.32 % 11.81 % 8.500 % (1 ) 8.00 % Total risk-based capital ratio 13.06 % 12.58 % 10.500 % (1 ) 10.00 % (1) Includes 2.5% capital conservation buffer.

Leases Leases (Tables)

Leases Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Summary of Operating Leases	The table below summarizes our net lease cost: For the three months ended March 31, (In thousands) 2020 2019 Operating lease cost $ 148 $ 150 Net lease cost $ 148 $ 150 The table below summarizes the cash and non-cash activities associated with our leases: For the three months ended March 31, (In thousands) 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 141 $ 142 ROU assets obtained in exchange for new operating lease liabilities $ — $ 2,765
Summary of Other Information for Operating Leases	The table below summarizes other information related to our operating leases: (In thousands, except percentages and years) March 31, 2020 December 31, 2019 Weighted average remaining lease term in years 6.57 6.76 Weighted average discount rate 5.48 % 5.47 % Operating lease right-of-use assets $ 2,667 $ 2,792
Maturity of Remaining Operating Lease Liabilities	The table below summarizes the maturity of remaining lease liabilities: (In thousands) March 31, 2020 2020 (excluding the three months ended March 31, 2020) $ 416 2021 528 2022 477 2023 410 2024 361 2025 and thereafter 1,036 Total lease payments $ 3,228 Less: Interest (526 ) Present value of lease liabilities $ 2,702

Net Income per Share (Details)

Net Income per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Net income	$ 5,368	$ 5,740
Weighted average common shares outstanding - Basic (in shares)	10,883	10,801
Plus: Potential dilutive common stock equivalents (in shares)	154	154
Weighted average common shares outstanding - Diluted (in shares)	11,037	10,955
Net income per common share - Basic (in dollars per share)	$ 0.49	$ 0.53
Net income per common share - Diluted (in dollars per share)	$ 0.49	$ 0.52
Stock options and common stock excluded from the income per share calculation as their effect would have been anti-dilutive (in shares)	363	209

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income tax expense	$ 1,598,000	$ 1,520,000
Effective income tax rate, continuing operations	22.90%	20.90%
Unrecognized tax benefits, income tax penalties and interest expense	$ 0	$ 0
Unrecognized tax benefits, income tax penalties and interest accrued	$ 0		$ 0
Income tax returns open tax years (2012 and thereafter)	2015

Other Comprehensive Income (L_3

Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	$ 160,709	$ 138,488
Other comprehensive income before reclassification	(1,135)	(62)
Less amounts reclassified from accumulated other comprehensive loss	(149)	(12)
Total other comprehensive income, net	(986)	(50)
Ending Balance	164,305	143,717
Reclassification to unappropriated retained earnings	74,939		$ 70,442
Net unrealized gains on securities
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	316	(721)
Other comprehensive income before reclassification	(131)	240
Less amounts reclassified from accumulated other comprehensive loss	(134)	79
Total other comprehensive income, net	3	161
Ending Balance	319	(560)
Adjustments related to defined benefit plan
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(295)	(431)
Other comprehensive income before reclassification	0	0
Less amounts reclassified from accumulated other comprehensive loss	(15)	(91)
Total other comprehensive income, net	15	91
Ending Balance	(280)	(340)
Net unrealized (losses) gains from cash flow hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	168	1,030
Other comprehensive income before reclassification	(1,004)	(302)
Less amounts reclassified from accumulated other comprehensive loss	0	0
Total other comprehensive income, net	(1,004)	(302)
Ending Balance	(836)	728
Accumulated other comprehensive (loss) income
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	154	(157)
Total other comprehensive income, net	(986)	(50)
Ending Balance	(832)	(207)
Accounting Standards Update 2016-01 And 2018-02
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Reclassification to unappropriated retained earnings	35
Accounting Standards Update 2016-01 And 2018-02 | Accumulated other comprehensive (loss) income
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	189	(122)
Ending Balance	$ (797)	$ (172)

Fair Value - Fair Value on Recu

Fair Value - Fair Value on Recurring Basis - Narrative (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Estimated fair value	$ 56,290	$ 64,275
Percentage of portfolio in residential mortgage backed securities	42.00%
Residential mortgage backed securities guaranteed by Government National Mortgage Association or Federal National Mortgage Association or Federal Home Loan Mortgage Corporation	$ 23,600
Equity securities	1,712	2,289
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Estimated fair value	$ 23,850	$ 27,964

Fair Value - Fair Value on Nonr

Fair Value - Fair Value on Nonrecurring Basis - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired financing receivable, related allowance	$ 184	$ 414
Decrease in valuation allowance for impaired loans	230
Letter of Credit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Standby letter of credit	$ 4,900	$ 4,800

Fair Value - Assets And Liabili

Fair Value - Assets And Liabilities Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	$ 56,290	$ 64,275
Loans held for sale	11,658	14,862
Equity securities	1,712	2,289
Interest rate swap agreements	(1,173)	238
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	0	0
Loans held for sale	0
Equity securities	0	0
Interest rate swap agreements	0	0
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	56,290	64,275
Loans held for sale	11,658	14,862
Equity securities	1,712	2,289
Interest rate swap agreements	(1,173)	238
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	0	0
Loans held for sale	0
Equity securities	0	0
Interest rate swap agreements	0	0
U.S. Government sponsored entities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	5,781	5,753
U.S. Government sponsored entities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	0	0
U.S. Government sponsored entities | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	5,781	5,753
U.S. Government sponsored entities | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	0	0
State and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	3,439	5,154
State and political subdivisions | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	0	0
State and political subdivisions | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	3,439	5,154
State and political subdivisions | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	0	0
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	23,850	27,964
Residential mortgage-backed securities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	0	0
Residential mortgage-backed securities | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	23,850	27,964
Residential mortgage-backed securities | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	0	0
Corporate and other securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	23,220	25,404
Corporate and other securities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	0	0
Corporate and other securities | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	23,220	25,404
Corporate and other securities | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available-for-sale	0	$ 0
Interest rate swap agreements
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap agreements	(1,173)
Interest rate swap agreements | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap agreements	0
Interest rate swap agreements | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap agreements	(1,173)
Interest rate swap agreements | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap agreements	$ 0

Fair Value - Assets and Liabi_2

Fair Value - Assets and Liabilities Subject to Fair Value Adjustments (Impairment) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
OREO	$ 1,523	$ 1,723
Impaired collateral-dependent loans	2,323	1,925
OREO, Net Provision (Credit)	(200)	(231)
Impaired collateral-dependent loans, Net Provision (Credit)	(230)	(253)
Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
OREO	0	0
Impaired collateral-dependent loans	0	0
Fair Value, Inputs, Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
OREO	0	0
Impaired collateral-dependent loans	0	0
Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
OREO	1,523	1,723
Impaired collateral-dependent loans	$ 2,323	$ 1,925

Fair Value - Carrying Amount an

Fair Value - Carrying Amount and Fair Values (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Financial assets:
SBA loans held for sale	$ 11,658	$ 14,862
Accrued interest receivable	7,396	6,984
Financial liabilities:
Accrued interest payable	237	455
Impaired collateral-dependent loans	2,323	1,925
Fair Value, Inputs, Level 1
Financial assets:
SBA loans held for sale	0
Financial liabilities:
Impaired collateral-dependent loans	0	0
Fair Value, Inputs, Level 2
Financial assets:
SBA loans held for sale	11,658	14,862
Financial liabilities:
Impaired collateral-dependent loans	0	0
Fair Value, Inputs, Level 3
Financial assets:
SBA loans held for sale	0
Financial liabilities:
Impaired collateral-dependent loans	2,323	1,925
Estimated fair value | Fair Value, Inputs, Level 1
Financial assets:
Cash and cash equivalents	178,995	158,016
Estimated fair value | Fair Value, Inputs, Level 2
Financial assets:
Securities	58,002	66,564
SBA loans held for sale	11,658	14,862
Loans, net of allowance for loan losses	1,427,787	1,398,997
FHLB stock	9,054	14,184
Accrued interest receivable	7,396	6,984
Financial liabilities:
Deposits	1,385,200	1,252,082
Borrowed funds and subordinated debentures	180,911	292,766
Accrued interest payable	237	455
Estimated fair value | Fair Value, Inputs, Level 3
Financial assets:
Servicing assets	2,138	2,026
OREO	1,523	1,723
Reported Value Measurement | Fair Value, Inputs, Level 1
Financial assets:
Cash and cash equivalents	178,995	158,016
Reported Value Measurement | Fair Value, Inputs, Level 2
Financial assets:
Securities	58,002	66,564
SBA loans held for sale	10,726	13,529
Loans, net of allowance for loan losses	1,411,543	1,395,634
FHLB stock	9,054	14,184
Accrued interest receivable	7,396	6,984
Financial liabilities:
Deposits	1,378,618	1,250,114
Borrowed funds and subordinated debentures	179,310	293,310
Accrued interest payable	237	455
Reported Value Measurement | Fair Value, Inputs, Level 3
Financial assets:
Servicing assets	2,138	2,026
OREO	$ 1,523	$ 1,723

Securities - Amortized Cost to

Securities - Amortized Cost to Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Available for sale at fair value:
Amortized cost	$ 55,894	$ 63,883
Gross unrealized gains	913	780
Gross unrealized losses	(517)	(388)
Estimated fair value	56,290	64,275
Equity Securities:
Amortized cost	2,112	2,218
Gross unrealized gains	0	142
Gross unrealized losses	(400)	(71)
Estimated fair value	1,712	2,289
U.S. Government sponsored entities
Available for sale at fair value:
Amortized cost	5,749	5,751
Gross unrealized gains	32	4
Gross unrealized losses	0	(2)
Estimated fair value	5,781	5,753
State and political subdivisions
Available for sale at fair value:
Amortized cost	3,581	4,992
Gross unrealized gains	7	174
Gross unrealized losses	(149)	(12)
Estimated fair value	3,439	5,154
Residential mortgage-backed securities
Available for sale at fair value:
Amortized cost	23,293	27,698
Gross unrealized gains	639	372
Gross unrealized losses	(82)	(106)
Estimated fair value	23,850	27,964
Corporate and other securities
Available for sale at fair value:
Amortized cost	23,271	25,442
Gross unrealized gains	235	230
Gross unrealized losses	(286)	(268)
Estimated fair value	$ 23,220	$ 25,404

Securities - Securities by Cont

Securities - Securities by Contractual Maturity (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Available for sale at fair value:
Available for sale at fair value, Within one year	$ 3,973
Available for sale at fair value yield, Within one year	1.72%
Available for sale at fair value, After one through five years	$ 4,537
Available for sale at fair value yield, After one through five years	2.88%
Available for sale at fair value, After five through ten years	$ 20,450
Available for sale at fair value yield, After five through ten years	4.37%
Available for sale at fair value, After ten years	$ 27,330
Available for sale at fair value yield, After ten years	3.19%
Available-for-sale Securities	$ 56,290
Available for sale at fair value yield	3.49%
Equity Securities:
Equity securities, Within one year	$ 0
Equity securities, Within one year, Yield	0.00%
Equity securities, After one through five years	$ 0
Equity securities, Within one year, Yield	0.00%
Equity securities, After ten years	$ 0
Equity securities, After ten years, Yield	0.00%
Equity securities, After ten years	$ 1,712
Equity securities, After ten years, Yield	2.72%
Equity securities	$ 1,712	$ 2,289
Equity securities, Yield	2.72%
U.S. Government sponsored entities
Available for sale at fair value:
Available for sale at fair value, Within one year	$ 3,776
Available for sale at fair value yield, Within one year	1.61%
Available for sale at fair value, After one through five years	$ 2,005
Available for sale at fair value yield, After one through five years	2.16%
Available for sale at fair value, After five through ten years	$ 0
Available for sale at fair value yield, After five through ten years	0.00%
Available for sale at fair value, After ten years	$ 0
Available for sale at fair value yield, After ten years	0.00%
Available-for-sale Securities	$ 5,781
Available for sale at fair value yield	1.80%
State and political subdivisions
Available for sale at fair value:
Available for sale at fair value, Within one year	$ 195
Available for sale at fair value yield, Within one year	3.80%
Available for sale at fair value, After one through five years	$ 600
Available for sale at fair value yield, After one through five years	3.92%
Available for sale at fair value, After five through ten years	$ 1,748
Available for sale at fair value yield, After five through ten years	3.16%
Available for sale at fair value, After ten years	$ 896
Available for sale at fair value yield, After ten years	2.74%
Available-for-sale Securities	$ 3,439
Available for sale at fair value yield	3.22%
Residential mortgage-backed securities
Available for sale at fair value:
Available for sale at fair value, Within one year	$ 2
Available for sale at fair value yield, Within one year	4.76%
Available for sale at fair value, After one through five years	$ 322
Available for sale at fair value yield, After one through five years	2.35%
Available for sale at fair value, After five through ten years	$ 2,331
Available for sale at fair value yield, After five through ten years	2.48%
Available for sale at fair value, After ten years	$ 21,195
Available for sale at fair value yield, After ten years	2.80%
Available-for-sale Securities	$ 23,850
Available for sale at fair value yield	2.76%
Corporate and other securities
Available for sale at fair value:
Available for sale at fair value, Within one year	$ 0
Available for sale at fair value yield, Within one year	0.00%
Available for sale at fair value, After one through five years	$ 1,610
Available for sale at fair value yield, After one through five years	3.49%
Available for sale at fair value, After five through ten years	$ 16,371
Available for sale at fair value yield, After five through ten years	4.77%
Available for sale at fair value, After ten years	$ 5,239
Available for sale at fair value yield, After ten years	4.87%
Available-for-sale Securities	$ 23,220
Available for sale at fair value yield	4.70%

Securities - Securities in Unre

Securities - Securities in Unrealized Loss Position (Details) $ in Thousands	Mar. 31, 2020USD ($)security	Dec. 31, 2019USD ($)security
Available for sale at fair value:
Available for sale, Total number in a loss position | security	16	18
Available for sale, Less than 12 months Estimated fair value	$ 7,083	$ 7,073
Available for sale, Less than 12 months, Unrealized loss	(176)	(40)
Available for sale, 12 Months and greater Estimated fair value	7,696	11,739
Available for sale, 12 Months and greater Unrealized loss	(341)	(348)
Available for sale, Estimated fair value	14,779	18,812
Available for sale, Unrealized loss	$ 517	$ 388
U.S. Government sponsored entities
Available for sale at fair value:
Available for sale, Total number in a loss position | security		1
Available for sale, Less than 12 months Estimated fair value		$ 0
Available for sale, Less than 12 months, Unrealized loss		0
Available for sale, 12 Months and greater Estimated fair value		1,995
Available for sale, 12 Months and greater Unrealized loss		(2)
Available for sale, Estimated fair value		1,995
Available for sale, Unrealized loss		$ 2
State and political subdivisions
Available for sale at fair value:
Available for sale, Total number in a loss position | security	3	1
Available for sale, Less than 12 months Estimated fair value	$ 1,246	$ 0
Available for sale, Less than 12 months, Unrealized loss	(109)	0
Available for sale, 12 Months and greater Estimated fair value	896	1,013
Available for sale, 12 Months and greater Unrealized loss	(40)	(12)
Available for sale, Estimated fair value	2,142	1,013
Available for sale, Unrealized loss	$ 149	$ 12
Residential mortgage-backed securities
Available for sale at fair value:
Available for sale, Total number in a loss position | security	7	10
Available for sale, Less than 12 months Estimated fair value	$ 2,526	$ 3,707
Available for sale, Less than 12 months, Unrealized loss	(12)	(27)
Available for sale, 12 Months and greater Estimated fair value	3,042	4,996
Available for sale, 12 Months and greater Unrealized loss	(70)	(79)
Available for sale, Estimated fair value	5,568	8,703
Available for sale, Unrealized loss	$ 82	$ 106
Corporate and other securities
Available for sale at fair value:
Available for sale, Total number in a loss position | security	6	6
Available for sale, Less than 12 months Estimated fair value	$ 3,311	$ 3,366
Available for sale, Less than 12 months, Unrealized loss	(55)	(13)
Available for sale, 12 Months and greater Estimated fair value	3,758	3,735
Available for sale, 12 Months and greater Unrealized loss	(231)	(255)
Available for sale, Estimated fair value	7,069	7,101
Available for sale, Unrealized loss	$ 286	$ 268

Securities - Realized Gains and

Securities - Realized Gains and Losses (Details)	3 Months Ended
	Mar. 31, 2020USD ($)security	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)
Schedule of Investments [Line Items]
Realized gains	$ 296,000	$ 0
Realized losses	0	0
Total debt securities available for sale	296,000	0
Net gains on sales of securities	296,000	$ 0
Securities realized gain (loss)	11,000
Available-for-sale securities pledged as collateral	$ 3,500,000		$ 4,000,000
1 Corporate Bond | Corporate Bond Securities
Schedule of Investments [Line Items]
Number of securities sold | security	1
Book value of securities sold	$ 2,200,000
Securities realized gain (loss)	$ 61,000
3 Mortgage Backed Securities | Commercial mortgage-backed securities
Schedule of Investments [Line Items]
Number of securities sold | security	3
Book value of securities sold	$ 2,800,000
Securities realized gain (loss)	$ 57,000
1 Security Sold | Municipal Securities
Schedule of Investments [Line Items]
Number of securities sold | security	1
Book value of securities sold	$ 381,000
Securities realized gain (loss)	$ 27,000
1 Security Sold | Taxable Municipal Securities
Schedule of Investments [Line Items]
Number of securities sold | security	1
Book value of securities sold	$ 456,000
Securities realized gain (loss)	$ 140,000
1 Security Called | Municipal Securities
Schedule of Investments [Line Items]
Number of securities sold | security	1
Book value of securities sold	$ 485,000

Securities - Realized Gains (Lo

Securities - Realized Gains (Losses) for Equity Securities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Marketable Securities [Abstract]
Net (losses) gains recognized during the period on equity securities	$ (471)	$ 100
Net gains recognized during the period on equity securities sold during the period	5	0
Unrealized (losses) gains recognized during the reporting period on equity securities still held at the reporting date	$ (466)	$ 100

Loans - Narrative (Details)

Loans - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Guarantee percentage of SBA Loan	90.00%
Residential Consumer Properties
Other real estate owned	$ 1.5	$ 1.7
Residential loans in process of foreclosure	$ 4.3	$ 3.6

Loans - Classification of Loans

Loans - Classification of Loans By Class (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	$ 1,428,919	$ 1,412,029
SBA loans held for sale	10,726	13,529
Total loans	1,439,645	1,425,558
Residential mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	456,072	467,706
Consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	149,695	143,524
SBA loans held for investment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	37,074	35,767
SBA 504 loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	25,185	26,726
Commercial loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	786,078	765,032
Commercial loans | Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	120,029	112,014
Commercial loans | Commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	586,336	578,643
Commercial loans | Commercial real estate construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	54,528	47,649
Residential mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	456,072	467,706
Consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	149,695	143,524
Consumer loans | Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	74,455	73,935
Consumer loans | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for investment	$ 75,240	$ 69,589

Loans - Credit Quality Indicato

Loans - Credit Quality Indicators (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	$ 1,428,919	$ 1,412,029
SBA loans held for investment
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	37,074	35,767
SBA loans held for investment | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	35,994	34,202
SBA loans held for investment | Special mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	0	1,115
SBA loans held for investment | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	1,080	450
SBA 504 loans
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	25,185	26,726
SBA 504 loans | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	23,374	24,878
SBA 504 loans | Special mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	1,779	1,808
SBA 504 loans | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	32	40
Commercial loans
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	786,078	765,032
Commercial loans | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	120,029	112,014
Commercial loans | Commercial real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	586,336	578,643
Commercial loans | Commercial real estate construction
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	54,528	47,649
Commercial loans | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	776,786	756,073
Commercial loans | Pass | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	114,840	107,220
Commercial loans | Pass | Commercial real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	584,044	576,326
Commercial loans | Pass | Commercial real estate construction
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	54,528	47,649
Commercial loans | Special mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	6,053	5,927
Commercial loans | Special mention | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	3,525	3,361
Commercial loans | Special mention | Commercial real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	749	758
Commercial loans | Special mention | Commercial real estate construction
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	0	0
Commercial loans | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	3,239	3,032
Commercial loans | Substandard | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	1,664	1,433
Commercial loans | Substandard | Commercial real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	1,543	1,559
Commercial loans | Substandard | Commercial real estate construction
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	0	0
Total SBA, SBA 504 and commercial loans
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	823,152	800,799
Total SBA, SBA 504 and commercial loans | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	812,780	790,275
Total SBA, SBA 504 and commercial loans | Special mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	6,053	7,042
Total SBA, SBA 504 and commercial loans | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	4,319	3,482
Residential mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	456,072	467,706
Residential mortgage loans | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	449,162	463,770
Residential mortgage loans | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	6,910	3,936
Consumer loans
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	149,695	143,524
Consumer loans | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	74,455	73,935
Consumer loans | Home equity
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	75,240	69,589
Consumer loans | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	149,190	143,504
Consumer loans | Performing | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	74,455	73,915
Consumer loans | Performing | Home equity
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	74,735	69,589
Consumer loans | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	505	20
Consumer loans | Nonperforming | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	0	20
Consumer loans | Nonperforming | Home equity
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	505	0
Total residential mortgage and consumer loans
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	605,767	611,230
Total residential mortgage and consumer loans | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	598,352	607,274
Total residential mortgage and consumer loans | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans held for investment	$ 7,415	$ 3,956

Loans - Aging Analysis of Past

Loans - Aging Analysis of Past Due and Nonaccrual Loans by Class (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	$ 18,580	$ 17,517
Loans receivable, nonaccrual status	9,655	5,649
Loan receivable, current	1,421,065	1,408,041
Total loans held for investment	1,410,339	1,394,512
Total loans	1,428,919	1,412,029
SBA loans held for sale	10,726	13,529
Total loans	1,439,645	1,425,558
30-59 days past due
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	7,923	7,163
60-89 days past due
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	1,002	3,775
90 days and still accruing
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	930
SBA loans held for investment
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	1,912	2,212
Loans receivable, nonaccrual status	1,627	1,164
Loan receivable, current	35,162	33,555
Total loans	37,074	35,767
SBA loans held for investment | 30-59 days past due
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	131	1,048
SBA loans held for investment | 60-89 days past due
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	154	0
SBA loans held for investment | 90 days and still accruing
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	0
SBA 504 loans
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	1,808
Loans receivable, nonaccrual status	0	0
Loan receivable, current	25,185	24,918
Total loans	25,185	26,726
SBA 504 loans | 30-59 days past due
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	0
SBA 504 loans | 60-89 days past due
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	1,808
SBA 504 loans | 90 days and still accruing
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	0
Commercial loans
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	786,078	765,032
Commercial loans | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	637	387
Loans receivable, nonaccrual status	0	316
Loan receivable, current	119,392	111,627
Total loans	120,029	112,014
Commercial loans | Commercial real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	1,473	428
Loans receivable, nonaccrual status	613	213
Loan receivable, current	584,863	578,215
Total loans	586,336	578,643
Commercial loans | Commercial real estate construction
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	0
Loans receivable, nonaccrual status	0	0
Loan receivable, current	54,528	47,649
Total loans	54,528	47,649
Commercial loans | 30-59 days past due | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	566	71
Commercial loans | 30-59 days past due | Commercial real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	785	215
Commercial loans | 30-59 days past due | Commercial real estate construction
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	0
Commercial loans | 60-89 days past due | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	71	0
Commercial loans | 60-89 days past due | Commercial real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	75	0
Commercial loans | 60-89 days past due | Commercial real estate construction
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	0
Commercial loans | 90 days and still accruing | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	0
Commercial loans | 90 days and still accruing | Commercial real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	0
Commercial loans | 90 days and still accruing | Commercial real estate construction
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	0
Residential mortgage loans
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	13,163	10,925
Loans receivable, nonaccrual status	6,910	3,936
Loan receivable, current	442,909	456,781
Total loans	456,072	467,706
Residential mortgage loans | 30-59 days past due
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	5,880	4,383
Residential mortgage loans | 60-89 days past due
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	373	1,676
Residential mortgage loans | 90 days and still accruing
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	930
Consumer loans
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	149,695	143,524
Consumer loans | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	133
Loans receivable, nonaccrual status	0	20
Loan receivable, current	74,455	73,802
Total loans	74,455	73,935
Consumer loans | Home equity
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	1,395	1,624
Loans receivable, nonaccrual status	505	0
Loan receivable, current	73,845	67,965
Total loans	75,240	69,589
Consumer loans | 30-59 days past due | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	0
Consumer loans | 30-59 days past due | Home equity
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	561	1,446
Consumer loans | 60-89 days past due | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	113
Consumer loans | 60-89 days past due | Home equity
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	329	178
Consumer loans | 90 days and still accruing | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	0
Consumer loans | 90 days and still accruing | Home equity
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, past due	0	0
Collateral Pledged | Small Business Administration
Financing Receivable, Credit Quality Indicator [Line Items]
Loans receivable, nonaccrual status	$ 427	$ 59

Loans - Impaired Loans with Ass

Loans - Impaired Loans with Associated Allowance (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)loan	Dec. 31, 2019USD ($)
Unpaid principal balance
Unpaid principal balance, with no related allowance	$ 2,634	$ 1,437
Unpaid principal balance, with related allowance	857	1,678
Unpaid principal balance	3,491	3,115
Recorded investment
Recorded investment, with no related allowance	1,675	1,277
Recorded investment, with related allowance	832	1,062
Recorded investment	2,507	2,339
Specific reserves	184	414
Loans receivable, nonaccrual status	9,655	5,649
Increase (decrease) in impaired Loans	376
SBA loans held for investment
Unpaid principal balance
Unpaid principal balance, with no related allowance	1,221	1,224
Unpaid principal balance, with related allowance	163	157
Unpaid principal balance	1,384	1,381
Recorded investment
Recorded investment, with no related allowance	1,062	1,064
Recorded investment, with related allowance	138	41
Recorded investment	1,200	1,105
Specific reserves	138	41
Loans receivable, nonaccrual status	1,627	1,164
SBA 504 loans
Recorded investment
Loans receivable, nonaccrual status	0	0
Commercial loans
Unpaid principal balance
Unpaid principal balance, with no related allowance	1,413	213
Unpaid principal balance, with related allowance	694	1,521
Unpaid principal balance	2,107	1,734
Recorded investment
Recorded investment, with no related allowance	613	213
Recorded investment, with related allowance	694	1,021
Recorded investment	1,307	1,234
Specific reserves	46	373
Commercial loans | Other
Unpaid principal balance
Unpaid principal balance, with no related allowance	500
Unpaid principal balance, with related allowance		816
Unpaid principal balance	500	816
Recorded investment
Recorded investment, with no related allowance	0
Recorded investment, with related allowance		316
Recorded investment	0	316
Specific reserves	0	316
Loans receivable, nonaccrual status	0	316
Commercial loans | Commercial real estate
Unpaid principal balance
Unpaid principal balance, with no related allowance	913	213
Unpaid principal balance, with related allowance	694	705
Unpaid principal balance	1,607	918
Recorded investment
Recorded investment, with no related allowance	613	213
Recorded investment, with related allowance	694	705
Recorded investment	1,307	918
Specific reserves	46	57
Loans receivable, nonaccrual status	613	213
Commercial loans | Commercial real estate construction
Recorded investment
Loans receivable, nonaccrual status	0	0
Collateral Pledged | Small Business Administration
Recorded investment
Loans receivable, nonaccrual status	$ 427	$ 59
Addition To Impaired Loans | Commercial loans
Recorded investment
Number of loans | loan	1
Financing receivable	$ 913
Paydown On Loans | Commercial loans
Recorded investment
Number of loans | loan	2
Financing receivable	$ 529

Loans - Average Recorded Invest

Loans - Average Recorded Investments and Interest Recognized (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Financing Receivable, Impaired [Line Items]
Average recorded investment	$ 2,780	$ 2,979
Interest income recognized on impaired loans	57	13
SBA loans held for investment
Financing Receivable, Impaired [Line Items]
Average recorded investment	1,128	1,183
Interest income recognized on impaired loans	3	4
SBA 504 loans
Financing Receivable, Impaired [Line Items]
Average recorded investment	600	0
Interest income recognized on impaired loans	32	0
Commercial loans | Other
Financing Receivable, Impaired [Line Items]
Average recorded investment	5	7
Interest income recognized on impaired loans	10	0
Commercial loans | Commercial real estate
Financing Receivable, Impaired [Line Items]
Average recorded investment	1,047	1,789
Interest income recognized on impaired loans	12	9
Small Business Administration
Financing Receivable, Impaired [Line Items]
Impaired financing receivable average recorded investment, guaranteed by Small Business Administration	$ 182	$ 100

Loans - Troubled Debt Restructu

Loans - Troubled Debt Restructuring (Narrative) (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2020USD ($)loan	Mar. 31, 2019USD ($)loan	Dec. 31, 2019USD ($)loan
Financing Receivable, Impaired [Line Items]
Average recorded investment	$ 2,780	$ 2,979
Impaired financing receivable, related allowance	184		$ 414
Loans receivable, nonaccrual status	$ 9,655		5,649
Number of loans modified as a TDR | loan	0	0
Number of loans modified as TDR, subsequent default | loan	0
Troubled Debt Restructuring (TDR) | Performing
Financing Receivable, Impaired [Line Items]
Average recorded investment	$ 694		705
Impaired financing receivable, related allowance	$ 46		$ 57
Number of loans modified as a TDR | loan	1		1

Allowance for Loan Losses and_3

Allowance for Loan Losses and Reserve for Unfunded Loan Commitments - Narrative (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Allowance for loan losses	$ 17,376	$ 16,395	$ 15,684	$ 15,488
Other commitment	$ 288	$ 273

Allowance for Loan Losses and_4

Allowance for Loan Losses and Reserve for Unfunded Loan Commitments - Activity in Allowance for Loan Losses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	$ 16,395	$ 15,488
Charge-offs	(525)	(310)
Recoveries	6	6
Net (charge-offs) recoveries	(519)	(304)
Provision for loan losses charged to expense	1,500	500
Ending Balance	17,376	15,684
SBA loans held for investment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	1,079	1,655
Charge-offs	(25)	(308)
Recoveries	5	1
Net (charge-offs) recoveries	(20)	(307)
Provision for loan losses charged to expense	(54)	330
Ending Balance	1,005	1,678
Total commercial loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	9,722	8,705
Charge-offs	(300)	(1)
Recoveries	1	5
Net (charge-offs) recoveries	(299)	4
Provision for loan losses charged to expense	706	84
Ending Balance	10,129	8,793
Residential mortgage loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	4,254	3,900
Charge-offs	(200)	0
Recoveries	0	0
Net (charge-offs) recoveries	(200)	0
Provision for loan losses charged to expense	709	116
Ending Balance	4,763	4,016
Total consumer loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	1,340	1,228
Charge-offs	0	(1)
Recoveries	0	0
Net (charge-offs) recoveries	0	(1)
Provision for loan losses charged to expense	139	(30)
Ending Balance	$ 1,479	$ 1,197

Allowance for Loan Losses and_5

Allowance for Loan Losses and Reserve for Unfunded Loan Commitments - Allowance for Credit Losses on Basis of Impairment Method (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Financing Receivable, Allowance for Credit Loss [Line Items]
Total	$ 17,376	$ 16,395	$ 15,684	$ 15,488
Total loans	1,428,919	1,412,029
SBA loans held for investment
Financing Receivable, Allowance for Credit Loss [Line Items]
Individually evaluated for impairment	138	41
Collectively evaluated for impairment	867	1,038
Total	1,005	1,079	1,678	1,655
Individually evaluated for impairment	1,200	1,105
Collectively evaluated for impairment	30,497	34,662
Total loans	31,697	35,767
Total commercial loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Individually evaluated for impairment	46	373
Collectively evaluated for impairment	10,083	9,349
Total	10,129	9,722	8,793	8,705
Individually evaluated for impairment	1,307	1,234
Collectively evaluated for impairment	784,770	763,798
Total loans	786,077	765,032
Residential mortgage loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	4,763	4,254
Total	4,763	4,254	4,016	3,900
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	456,072	467,706
Total loans	456,072	467,706
Total consumer loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	1,479	1,340
Total	1,479	1,340	$ 1,197	$ 1,228
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	149,695	143,524
Total loans	149,695	143,524
Total
Financing Receivable, Allowance for Credit Loss [Line Items]
Individually evaluated for impairment	184	414
Collectively evaluated for impairment	17,192	15,981
Total	17,376	16,395
Individually evaluated for impairment	2,507	2,339
Collectively evaluated for impairment	1,421,034	1,409,690
Total loans	$ 1,423,541	$ 1,412,029

Derivative Financial Instrume_3

Derivative Financial Instruments and Hedging Activities (Details)	3 Months Ended
	Mar. 31, 2020USD ($)instrument	Mar. 31, 2019USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 100,000,000	$ 60,000,000
Fair value	$ (1,173,000)	$ 238,000
Weighted average pay rate	1.19%	1.42%
Weighted average receive rate	1.51%	2.19%
Weighted average maturity	2 years 6 months 28 days	1 year 3 months 1 day
Number of contracts	$ 6	$ 4
Interest Rate Swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 20,000,000
Number of derivative instruments | instrument	2

Derivative Financial Instrume_4

Derivative Financial Instruments and Hedging Activities - Gain (Loss) in AOCI (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Interest Rate Swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Unrealized losses relating to interest rate swaps	$ (1,410)	$ (381)

Employee Benefit Plans - Narrat

Employee Benefit Plans - Narrative (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)paymentshares	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)shares	Dec. 31, 2018USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, outstanding (in shares) | shares	709,811		614,311
Defined contribution plan, maximum annual contributions per employee, percent	80.00%
Defined contribution plan employer discretionary contribution amount	$ 185	$ 146
Deferred fees	491	312
Interest paid on deferred fees	28	23
Distributions paid	$ 2	3
Description of defined contribution pension and other postretirement plans	Upon separation from service after age 66, the President and CEO will be entitled to an annual benefit in the amount of $156,000 payable in fifteen annual installments subject to annual 2% increases.
Defined benefit plans future payments	$ 3,639	2,823	$ 3,571	$ 2,747
Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Deferred compensation arrangement guaranteed award percentage	100.00%
Executive Management
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Deferred compensation arrangement guaranteed award percentage	100.00%
Supplemental Employee Retirement Plan | President And Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Retirement benefit payable as percent of average Executive's base salary for 36 months preceding separation from service	60.00%
Payment term after separation	36 months
Retirement benefit payable as percent of average Executive's base salary for 36 months preceding separation from service, adjustment thereafter	2.00%
Number of annual payments after separation | payment	15
Expected future benefit payment	$ 6,600
Discount rate used to calculate the present value of the benefit obligation	4.00%
Vesting percentage	3.00%
Award vesting rights, percentage	100.00%
Other Postretirement Benefit Plan | Executive Management
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Deferred compensation arrangement guaranteed award percentage	7.50%
Award vesting rights, percentage	100.00%
Accrued expense under the plan	$ 24
Life insurance plan with a post retirement death benefit	250
Life insurance plan aggregate expenses	$ 1	$ 1
Other Postretirement Benefit Plan | Executive Management | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Deferred compensation arrangement guaranteed award percentage	15.00%
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	10 years
Options, award expiration period	3 years
Number of shares authorized | shares	327,100
Options, outstanding (in shares) | shares	500,000
Options, exercised forfeited or expired (shares) | shares	142,000
Number of shares available for grant | shares	30,900
Compensation cost not yet recognized	$ 1,500
Compensation cost recognition weighted average period	2 years 2 months 12 days
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognition weighted average period	2 years 8 months 12 days
Nonvested awards, compensation not yet recognized, awards other than options	$ 1,600

Employee Benefit Plans - Stock

Employee Benefit Plans - Stock Transactions - Stock Option Plans (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Shares
Options Outstanding, beginning shares	614,311
Options granted, shares	101,000	55,000
Options exercised, shares	(5,500)	(20,434)
Options forfeited, shares	0
Options expired, shares	0
Options Outstanding, ending shares	709,811		614,311
Shares Exercisable	436,981
Weighted average exercise price
Weighted average exercise price, Options Outstanding, beginning (in dollars per share)	$ 14.78
Weighted average exercise price, Options granted (in dollars per share)	20.39	$ 20.61
Weighted average exercise price, Options exercised (in dollars per share)	6.23
Weighted average exercise price, Options forfeited (in dollars per share)	0
Weighted average exercise price, Options expired (in dollars per share)	0
Weighted average exercise price, Options Outstanding, ending (in dollars per share)	15.65		$ 14.78
Weighted average exercise price, Options Exercisable (in dollars per share)	$ 12.55
Weighted average remaining contractual life , Options Outstanding	7 years 1 month 6 days		6 years 10 months 24 days
Weighted average remaining contractual life, Options exercisable	5 years 9 months 18 days
Aggregate intrinsic value: Options Outstanding	$ 926,893		$ 4,783,402
Aggregate intrinsic value, Options exercisable	$ 926,893

Employee Benefit Plans - Stoc_2

Employee Benefit Plans - Stock Option Valuation Assumptions (Details) - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Employee Benefit and Share-based Payment Arrangement, Noncash Expense [Abstract]
Number of options granted (shares)	101,000	55,000
Weighted average exercise price (in dollars per share)	$ 20.39	$ 20.61
Weighted average fair value of options (in dollars per share)	$ 5.54	$ 6.21
Expected life	8 years 7 months 28 days	8 years 2 months 23 days
Expected volatility	27.13%	27.08%
Risk-free interest rate	1.55%	2.55%
Dividend yield	1.61%	1.36%

Employee Benefit Plans - Schedu

Employee Benefit Plans - Schedule of Options Exercised (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Employee Benefit and Share-based Payment Arrangement, Noncash Expense [Abstract]
Number of options exercised (shares)	5,500	20,434
Cash received from options exercised	$ 34,265	$ 165,943
Total intrinsic value of options exercised	86,241	240,403
Tax deduction realized from options	$ 25,264	$ 72,325

Employee Benefit Plans - Stoc_3

Employee Benefit Plans - Stock Transactions - Stock Options Outstanding And Exercisable (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding: Shares Outstanding | shares	709,811
Options Outstanding: Weighted Average Remaining Contractual Life	7 years 1 month 6 days
Options Outstanding: Weighted Average Exercise Price (in dollars per share)	$ 15.65
Options Exercisable: Shares Exercisable | shares	436,981
Options Exercisable: Weighted Average Exercise Price (in dollars per share)	$ 12.55
$0.00 - $6.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of exercise prices, lower (in dollars per share)	0
Range of exercise prices, upper (in dollars per share)	$ 6
Options Outstanding: Shares Outstanding | shares	59,011
Options Outstanding: Weighted Average Remaining Contractual Life	2 years 4 months 24 days
Options Outstanding: Weighted Average Exercise Price (in dollars per share)	$ 5.60
Options Exercisable: Shares Exercisable | shares	59,011
Options Exercisable: Weighted Average Exercise Price (in dollars per share)	$ 5.60
$6.01 - $12.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of exercise prices, lower (in dollars per share)	6.01
Range of exercise prices, upper (in dollars per share)	$ 12
Options Outstanding: Shares Outstanding | shares	190,767
Options Outstanding: Weighted Average Remaining Contractual Life	5 years
Options Outstanding: Weighted Average Exercise Price (in dollars per share)	$ 8.73
Options Exercisable: Shares Exercisable | shares	190,767
Options Exercisable: Weighted Average Exercise Price (in dollars per share)	$ 8.73
$12.01 - $18.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of exercise prices, lower (in dollars per share)	12.01
Range of exercise prices, upper (in dollars per share)	$ 18
Options Outstanding: Shares Outstanding | shares	102,533
Options Outstanding: Weighted Average Remaining Contractual Life	7 years 10 months 24 days
Options Outstanding: Weighted Average Exercise Price (in dollars per share)	$ 15.94
Options Exercisable: Shares Exercisable | shares	67,533
Options Exercisable: Weighted Average Exercise Price (in dollars per share)	$ 15.78
$18.01 - $24.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of exercise prices, lower (in dollars per share)	18.01
Range of exercise prices, upper (in dollars per share)	$ 24
Options Outstanding: Shares Outstanding | shares	357,500
Options Outstanding: Weighted Average Remaining Contractual Life	8 years 9 months 18 days
Options Outstanding: Weighted Average Exercise Price (in dollars per share)	$ 20.91
Options Exercisable: Shares Exercisable | shares	119,670
Options Exercisable: Weighted Average Exercise Price (in dollars per share)	$ 20.26

Employee Benefit Plans - Compen

Employee Benefit Plans - Compensation Expense Related To Stock Options (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 192,489	$ 136,356
Income tax benefit	55,629	39,407
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	172,905	146,288
Income tax benefit	$ 49,969	$ 42,277

Employee Benefit Plans - Stoc_4

Employee Benefit Plans - Stock Transactions - Restricted Stock Activity (Details) - Restricted Stock - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Shares
Nonvested restricted stock: shares	108,740
Granted: shares	15,000	30,150
Cancelled: shares	0
Vested: shares	(33,718)
Nonvested restricted stock: shares	90,022
Average grant date fair value
Nonvested restricted stock: Average grant date fair value (in dollars per share)	$ 19.18
Granted: Average grant date fair value (in dollars per share)	16.63	$ 20.65
Cancelled: Average grant date fair value (in dollars per share)	0
Vested: Average grant date fair value (in dollars per share)	17.08
Nonvested restricted stock: Average grant date fair value (in dollars per share)	$ 19.54

Employee Benefit Plans - Stoc_5

Employee Benefit Plans - Stock Transactions - Restricted Stock Awards (Details) - Restricted Stock - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted	15,000	30,150
Average grant date fair value (in dollars per share)	$ 16.63	$ 20.65

Employee Benefit Plans - Net Pe

Employee Benefit Plans - Net Periodic Pension Cost of Defined Benefit Plan (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Employee Benefit and Share-based Payment Arrangement, Noncash Expense [Abstract]
Service cost	$ 31	$ 47
Interest cost	37	29
Amortization of prior service cost	21	21
Net periodic benefit cost	$ 89	$ 97

Employee Benefit Plans - Benefi

Employee Benefit Plans - Benefit Obligations of Defined Benefit Plan (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation, beginning of year	$ 3,571	$ 2,747
Service cost	31	47
Interest cost	37	29
Benefit obligation, end of year	$ 3,639	$ 2,823

Regulatory Capital (Details)

Regulatory Capital (Details)	Jan. 01, 2019	Mar. 31, 2020	Dec. 31, 2019
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Leverage ratio: Actual Ratio		10.56%	10.59%
CET1: Actual Ratio		11.67%	11.59%
Tier I risk-based capital ratio: Actual Ratio		12.39%	12.32%
Total risk--based capital ratio: Actual Ratio		13.15%	13.06%
Leverage ratio: For Capital Adequacy Purposes Ratio	4.00%		4.00%
CET1: For Capital Adequacy Purposes Ratio	7.00%		7.00%
Tier I risk-based capital ratio: For Capital Adequacy Purposes Ratio	8.50%		8.50%
Total risk-based capital ratio: For Capital Adequacy Purposes Ratio	10.50%		10.50%
Capital conservation buffer	2.50%
Bank
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Leverage ratio: Actual Ratio		10.16%	10.15%
CET1: Actual Ratio		11.91%	11.81%
Tier I risk-based capital ratio: Actual Ratio		11.91%	11.81%
Total risk--based capital ratio: Actual Ratio		12.70%	12.58%
Leverage ratio: To Be Well-Capitalized Under Prompt Corrective Action Provisions Ratio		5.00%	5.00%
CET1: To Be Well-Capitalized Under Prompt Corrective Action Provisions Ratio		6.50%	6.50%
Tier I risk-based capital ratio: To Be Well-Capitalized Under Prompt Corrective Action Provisions Ratio		8.00%	8.00%
Total risk-based capital ratio: To Be Well-Capitalized Under Prompt Corrective Action Provisions Ratio		10.00%	10.00%

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease right-of-use assets	$ 2,667	$ 2,792
Operating lease liability	$ 2,702	$ 2,800
Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Remaining term of contract	1 year
Renewal term	1 year
Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Remaining term of contract	10 years
Renewal term	5 years

Leases - Cost (Details)

Leases - Cost (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Leases [Abstract]
Operating lease cost	$ 148	$ 150
Net lease cost	148	150
Operating cash flows from operating leases	141	142
ROU assets obtained in exchange for new operating lease liabilities	$ 0	$ 2,765
Weighted average remaining lease term in years	6 years 6 months 26 days		6 years 9 months 4 days
Weighted average discount rate	5.48%		5.47%
Operating lease right-of-use assets	$ 2,667		$ 2,792

Leases - Maturity (Details)

Leases - Maturity (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Leases [Abstract]
2020 (excluding the three months ended March 31, 2020)	$ 416
2021	528
2022	477
2023	410
2024	361
2025 and thereafter	1,036
Total lease payments	3,228
Less: Interest	(526)
Present value of lease liabilities	$ 2,702	$ 2,800